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Abstract 
Biological membranes contain more than thousand different lipid classes and lipid species 
that are far from being fully characterized. In order to understand molecular processes 
that are connected to membrane lipids a continuous development of analytical methods is 
required. In this thesis, nano-electrospray ionization tandem mass spectrometry  
(nano-ESI-MS/MS) was employed to establish methods for the quantification of  
cardiolipin (CL), diacylglycerol (DAG) and the phosphoinositides PIP and PIP2. The 
methods were applied for the analysis of mitochondria, Golgi membranes and T cells in 
order to address scientific questions: 
 
I. The quantitative analysis of CL in mitochondria, isolated from yeast mutants, 
showed that GEP genes (genetic interactors of prohibitins) are involved in the 
regulation of mitochondrial phospholipids CL and phosphatidylethanolamine. 
Strikingly, the mass spectrometric identification of the lipid intermediate 
phosphatidylglycerolphosphate (PGP) in mitochondria from ∆gep4 mutants 
supported the identification of Gep4 as a novel PGP phosphatase required for CL 
biosynthesis. 
 
II. The quantitative analysis of DAG revealed that ilimaquinone (IQ)-induced 
vesiculation of the Golgi complex significantly affects the level of DAG. This result 
is consistent with previous observations that lipid-modifying enzymes, such as 
phospholipase D and PA phosphatase, are activated and suggests that membrane 
lipids play a critical role during the process of IQ-mediated Golgi vesiculation.  
 
III. The quantitative analysis of PIP, PIP2 and DAG in conventional T cells showed 
that T cell receptor (TCR)-induced stimulation significantly affects the level of 
signaling lipids. This result was an important readout to address the question 
whether regulatory T cells interfere with proximal lipid signaling events in con-
ventional T cells. 
 
Furthermore, a lipidome analysis of Golgi membranes and COPI vesicles was performed. 
The generated data confirmed previous findings that sphingomyelin and cholesterol are 
segregated during the formation of COPI vesicles. Moreover, the lipid analysis revealed 
that COPI vesicles display a lipid composition similar to the endoplasmatic reticulum, with 
elevated levels of phosphatidylcholine and phosphatidylinositol. The characteristic lipid 
composition supports the scenario that COPI vesicle formation occurs at liquid-disordered 
domains in the Golgi complex. 
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Zusammenfassung 
Biologische Membranen bestehen aus mehr als tausend verschiedenen Lipidklassen und 
Lipidspezies, welche bisher nur unvollständig charakterisiert sind. Mit dem Ziel molekulare 
Prozesse, an denen Membranlipide beteiligt sind, zu verstehen, bedarf es einer 
kontinuierlichen Weiterentwicklung analytischer Methoden. In dieser Arbeit wurde Nano-
Elektrospray-Ionisations-Tandem-Massenspektrometrie (Nano-ESI-MS/MS) verwendet, 
um Methoden für die Quantifizierung von Cardiolipin (CL), Diacylglycerol (DAG) und den 
Phosphoinositiden PIP und PIP2 zu etablieren. Mit dem Ziel wissenschaftliche Frage-
stellungen zu adressieren, wurden die Methoden für die Analyse von Mitochondrien, 
Golgi-Membranen und T-Zellen angewendet: 
 
I. Die Quantifizierung von CL in Mitochondrien, welche aus Hefemutanten isoliert 
wurden, zeigte, dass GEP Gene (Genetische Interaktoren von Prohibitinen) an der 
Regulation der mitochondrialen Phospholipide CL und Phosphatidylethanolamin 
beteiligt sind. Weiterhin unterstützte die massenspektrometrische Identifizierung 
des Lipidintermediates Phosphatidylglycerolphosphat (PGP) in Mitochondrien von 
∆gep4 Mutanten die Identifizierung von Gep4 als neuartige PGP-Phosphatase 
welche für die CL-Biosynthese benötigt wird.  
 
II. Die Quantifizierung von DAG zeigte, dass die Ilimaquinone (IQ)-induzierte 
Vesikulierung des Golgi-Komplexes einen signifikanten Einfluss auf DAG-Level 
hat. Dieser Effekt bestätigte, dass Lipid-modifizierende Enzyme, wie Phospho-
lipase D und PA-Phosphatase, aktiviert werden und lässt darauf schließen, dass 
Membranlipide eine entscheidende Rolle während der IQ-vermittelten Golgi-
Vesikulierung spielen. 
 
III. Die quantitative Analyse von PIP, PIP2 und DAG in konventionellen T-Zellen, 
zeigte, dass die T-Zell-Rezeptor (TZR)-induzierte Stimulierung einen signifikanten 
Einfluss auf die Mengen dieser Signallipide hat. Dieses Resultat war von 
Bedeutung für die weitere Fragestellung, ob regulatorische T-Zellen die proximale 
Lipid-Signalweiterleitung in konventionellen T-Zellen beeinflussen. 
 
Weiterhin wurde eine Lipidome-Analyse von Golgi-Membranen und COPI-Vesikeln durch-
geführt. Die erhobenen Daten bestätigten, dass Sphingomyelin und Cholesterin während 
der COPI-Vesikelbildung segregiert werden. Weiterhin zeigten die Lipidanalysen, dass 
COPI-Vesikel eine ähnliche Lipidzusammensetzung wie das Endoplasmatische Retikulum 
aufweisen, mit erhöhtem Gehalt an Phosphatidylcholin und Phosphatidylinositol. Die 
charakteristische Lipidzusammensetzung lässt darauf schließen, dass die Bildung von 
COPI-Vesikeln an „liquid-disordered“ Domänen innerhalb des Golgi-Komplexes statt-
findet.    
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1 Introduction 
1.1  Biological membranes 
Biological membranes are organized assemblies of lipids, proteins and carbohydrates that 
are required for barrier function, compartmentalization, transport and signaling processes 
in living cells. The plasma membrane (PM) and intracellular compartments such as the 
endoplasmatic reticulum (ER), the Golgi complex and mitochondria are characterized by 
distinct lipid compositions that reflect the various tasks that have to be fulfilled by different 
biological membranes (van Meer et al., 2008).  
 
The variety of lipids in cellular and organellar membranes is exceedingly complex with 
more than thousand different lipid classes and species (van Meer, 2005). According to a 
comprehensive classification system, lipids can be separated in eight different groups: 
fatty acids, glycerophospholipids, glycerolipids, sphingolipids, prenol lipids, saccharolipids, 
polyketides and sterols (Fahy et al., 2005). Of particular interest for the present work are 
glycerophospholipids, glycerolipids, sphingolipids and sterols that are introduced here with 
respect to their structure, synthesis and function.  
 
1.2 Structure, synthesis and function of membrane lipids  
1.2.1 Glycerophospholipids  
Glycerophospholipids consist of a glycerol moiety that is linked to a phosphate containing 
headgroup in sn-3 position and two fatty acids bound to the sn-1 and sn-2 position, 
respectively. The sn-1 position often contains saturated fatty acids, whereas unsaturated 
fatty acids are commonly attached to the sn-2 position. Phosphatidic acid (PA) (Figure 1), 
the simplest glycerophospholipid containing only a glycerolphosphate and two fatty acids, 
is an important signaling molecule and a key intermediate in the synthesis of other lipid 
classes (Athenstaedt and Daum, 1999). The phosphate group of PA can be further 
modified to generate other glycerophospholipids such as phosphatidylcholine (PC).  
 
PC (Figure 1), the most abundant glycerophospholipid in biological membranes, is 
synthesized mainly in the ER by the bifunctional enzyme DAG-choline/ethanolamine 
phosphotransferase (CEPT) via the Kennedy or CDP-choline pathway (Gibellini and 
Smith, 2010). In a first step, choline is phosphorylated to phosphocholine that is further 
converted to CDP-choline. CEPT catalyzes the reaction of CDP-choline and DAG to 
generate PC. The Golgi-located enzyme DAG-choline phosphotransferase (CPT) can also 
contribute to the cellular production of PC via the Kennedy pathway (Henneberry et al., 
Introduction 
_________________________________________________________________ 
14 
2002; Fagone and Jackowski, 2009). Alternatively, PC can be synthesized by sequential 
methylation of phosphatidylethanolamine (PE), catalyzed by the N-methyltransferases 
PEMT1 in the ER and PEMT2 in mitochondria-associated membranes (MAMs) (Cui et al., 
1993; Vance et al., 1997). MAMs represent membrane-connecting structures between ER 
and mitochondria that are involved in the biosynthesis and transport of lipids between both 
organelles (Hayashi et al., 2009). PC has a cylindrical shape and therefore spontaneously 
organizes into bilayers being an ideal structural component of membranes. In addition to 
its function as a membrane building block, PC has been linked to biological processes 
such as phospholipase-mediated signaling (Jackowski et al., 1997; Billah and Anthes, 
1990). 
 
The aminophospholipid PE (Figure 1) comprises an abundant lipid of biological mem-
branes that is synthesized via the Kennedy pathway in the ER by CEPT (Gibellini and 
Smith, 2010) or by a PE-specific DAG-ethanolamine phosphotransferase (EPT) (Horibata 
and Hirabayashi, 2007). Alternatively, the enzymatic action of a PS-decarboxylase (Psd) 
can also contribute to the production of PE. In yeast, two types of decarboxylases have 
been identified, Psd1 and Psd2, which are localized to the inner mitochondrial membrane 
and the Golgi/vacuolar membrane, respectively (Voelker, 1997). Only one mitochondria-
located PS decarboxylase (Psd1) has been identified in mammals (Vance, 2008). 
Although it seems that PE is quite similar to PC, regarding its function as a structural 
membrane lipid, there are some significant differences in the biophysical properties of 
these lipids. PE has a smaller headgroup than PC, which gives the lipid a cone shape. 
This property allows PE, similar to CL, the formation of non-bilayer structures in biological 
membranes (see chapter 1.2.1.1). 
 
The aminophospholipid phosphatidylserine (PS) (Figure 1) is synthesized by the reaction 
of serine with CDP-DAG, that is catalyzed in yeast, but not in mammals, by the  
PS synthase Cho1p in MAMs (Kohlwein et al., 1988; Vance and Steenbergen, 2005). 
In mammals, PS synthesis is catalyzed by two different base exchange enzymes, PS-
synthase 1 (Pss1) and PS-synthase 2 (Pss2) that exchange the choline and ethanolamine 
headgroups of PC and PE, respectively, for serine (Vance and Steenbergen, 2005). Both  
PS synthases are localized to MAMs (Stone and Vance, 2000). PS is found, together with 
PE, mainly in the inner leaflet of the PM where it can interact with proteins due to its 
negatively charged headgroup. For instance, the cytoskeletal protein spectrin binds to PS 
in erythrocytes and thus being involved in maintaining membrane integrity and mechanical 
stability (An et al., 2004). The loss of PS asymmetry at the PM is an indicator of apoptosis 
since PS is exposed to the outer leaflet in apoptotic cells as a result of decreased 
Introduction 
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aminophospholipid translocase activity and increased scramblase activity. The exposure 
of PS is an important signal for the recognition and removal of apoptotic cells by 
phagocytes (Fadok et al., 1998). Furthermore, PS has been associated with signaling 
processes acting as a cofactor for the activation of protein kinase C (PKC) together with 
DAG and Ca2+ (Newton, 1995). 
 
Phosphatidylglycerol (PG) (Figure 1) is a minor lipid in mammalian membranes but it is 
known as the main constituent of bacterial bilayers where it supports membrane stability 
(Zhao et al., 2008). PG is an important lipid intermediate in the biosynthesis of 
mitochondrial CL (see chapter 1.2.1.1). 
 
Phosphatidylinositol (PI) (Figure 1) is a glycerophospholipid consisting of a PA backbone 
that is linked via the phosphate group to myo-D-inositol (hexahydroxycyclohexane). The 
final step of PI synthesis, catalyzed by PI synthase, is the condensation of inositol and 
CDP-DAG (Antonsson, 1997). Most of de novo PI synthesis takes place at the ER, 
however, other intracellular sites of PI production have been assigned to the plasma 
membrane, the Golgi apparatus, the nucleus and to secretory vesicles (Monaco et al., 
2006). The fatty acid composition of PI in animal tissues is rather distinctive, since it 
contains mainly C18:0 and C20:4 fatty acids attached to the sn-1 and sn-2 position, 
respectively. Polyunsaturated PI is intracellular enriched at the ER, where it contributes to 
a loose packed and flexible ER-membrane, thus facilitating the insertion of newly 
synthesized lipids and proteins (van Meer et al., 2008). Furthermore, PI is the precursor of 
the phosphoinositides PIP, PIP2 and PIP3, which play fundamental roles in a variety of 
cellular processes (see chapter 1.2.1.2). 
 
Ether lipids, such as plasmalogen phosphatidylethanolamine (pl-PE) (Figure 1), comprise 
a class of glycerophospholipids that are produced by sequential action of several 
enzymes (Nagan and Zoeller, 2001). The first step of ether lipid synthesis is catalyzed by 
dihydroxyacetonphosphate-acyltransferase (DHAPAT) that produces acyl-DHAP in 
peroxisomes. In a second step, the ether bond is introduced by alkyl-DHAP synthase to 
form alkyl-DHAP. Depending on the specificity of the following enzymes, ether lipids with 
either an ether (O-alkyl) or a vinyl ether (O-alkenyl = plasmalogens) bond in the sn-1 
position of glycerol can be generated. The majority of the O-alkyl moieties generally occur 
as plasmanylcholines (PC-O), whereas the O-alkenyl group is mainly associated with 
plasmalogen phosphatidylethanolamines. A prominent member of ether lipids is the 
platelet-activation-factor (PAF), a plasmanylcholine with an acetate group in the sn-2 
position and a C16 fatty acid in the sn-1 position. PAF is a potent activator and mediator 
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of many leukocyte functions, including platelet aggregation and inflammation (Hanahan, 
1986). Furthermore, ether lipids have been linked to signaling processes (Smets et al., 
1999), antioxidative functions (Brosche and Platt, 1998) and membrane trafficking (Thai et 
al., 2001).  
 
Lysophospholipids are generated from their diacyl-precursors by specific action of the 
phospholipases A1 and A2 (Newkirk and Waite, 1973). Lysophosphatidylcholine (LPC) 
(Figure 1) for example is involved in signaling processes (Tan et al., 2009) and acts as an 
intermediate in the fatty acid remodeling of other glycerophospholipids such as cardiolipin 
(Xu et al., 2003). The inverted cone shape of lysophospholipids enables the induction of 
membrane curvature (Fuller and Rand, 2001), thereby supporting membrane fusion and 
fission events. Consistently, lysophospholipids have been associated with Golgi mem-
brane dynamics and vesicular trafficking (Bankaitis, 2009; Drecktrah et al., 2003). 
 
1.2.1.1 Cardiolipin (CL) 
CL is a dimeric glycerophospholipid (Figure 1) that is found in bacteria and mitochondrial 
membranes of eukaryotic cells. CL is mainly located in the inner mitochondrial membrane 
and to a minor extend also present in the outer mitochondrial membrane (Daum and 
Vance, 1997; Gebert et al., 2009; Schlame, 2008). In yeast cells, mitochondrial CL is a 
rather low abundant class of lipids, accounting to ~1 mol% of the lipidome (Ejsing et al., 
2009). CL can be enriched to ~15 mol% in isolated mitochondrial fractions (Daum and 
Vance, 1997).  
 
The synthesis of CL in yeast mitochondria requires that PA is transferred from the outer to 
the inner membrane, where it is activated by the CDP-diacylglycerol synthase Cds1 to 
CDP-DAG (Kuchler et al., 1986). CDP-DAG, together with glycerol-3-phosphate, is 
converted to phosphatidylglycerolphosphate (PGP) (Figure 1) by the PGP synthase Pgs1 
(Chang et al., 1998a). The low abundant lipid intermediate PGP is rapidly de-
phosphorylated to PG by the recently identified PGP phosphatase Gep4 (Osman et al., 
2010). In the final step, a pool of “premature” CL species is synthesized by the  
cardiolipin synthase Crd1 through condensation of PG with CDP-DAG. “Premature” CL, 
characterized by a high degree of saturated fatty acids, undergoes acyl chain remodeling 
to produce a “mature” pool of CL species that contain fatty acids with a higher degree of 
unsaturation. This process is initiated by the CL-specific phospholipase Cld1 (Beranek et 
al., 2009), which generates monolysocardiolipin (MLCL). The transacylase taffazin (Taz1) 
incorporates unsaturated fatty acids onto MLCL to generate “mature” CL (Gu et al., 2004). 
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In most cases, “mature” CL species contain only two types of fatty acids which results in a 
high degree of structural uniformity and molecular symmetry of CL species (Schlame et 
al., 2005). The physiological importance of symmetric CL species is supported by the fact 
that Barth syndrome patients (BTHS) contain CL species with an aberrant fatty acid 
distribution (Valianpour et al., 2002; Valianpour et al., 2005). Aberrant CL species of 
BTHS affect the stability of respiratory chain supercomplexes in mitochondrial membranes 
(McKenzie et al., 2006), accordingly, syndromes of BTHS, such as cardiomyopathy, 
neutropenia and muscle weakness, can be ascribed to an impaired energy production in 
mitochondria.  
 
CL is structurally related to PE since both molecules are able to form non-bilayer, hexa-
gonal phases in membranes  (Verkleij et al., 1984; Cullis and de Kruijff, 1978; Vasilenko et 
al., 1982). Hexagonal phase structures are discussed to be required for the formation of 
membrane contact sites during fusion and fission processes and in transmembrane move-
ment of proteins (Cullis and de Kruijff, 1979; van den Brink-van der Laan et al., 2004; 
Schlame et al., 2000). Consistently, PE- and CL-rich domains have been discovered in 
bacterial membranes where they might serve as platforms for fusion and fission events 
(Matsumoto et al., 2006). Furthermore, CL has been linked to a variety of mitochondrial 
and cellular processes such as energy production (Pfeiffer et al., 2003), apoptosis 
(McMillin and Dowhan, 2002; Ostrander et al., 2001) and diseases like diabetes (Han et 
al., 2007) and cancer (Kiebish et al., 2008). 
 
1.2.1.2 Phosphoinositides (PIPs) 
PIPs are low abundant lipid classes in biological membranes accounting to ~0.1-1 mol% 
(PIP and PIP2) (Figure 1) and <0.0002 mol% (PIP3) (Mallo et al., 2008). For the bio-
synthesis of PIPs, the precursor PI needs to be transported from the ER to different 
organelles, where PIPs are metabolically generated and interconverted by the enzymatic 
action of several kinases and phosphatases (Downes et al., 2005; Sasaki et al., 2009; 
Tolias and Cantley, 1999; Blero et al., 2007). Dependent on the side and extend of 
phosphorylation, seven distinct phosphoinositide classes are known in nature: PI(3)P, 
PI(4)P, PI(5)P, PI(3,4)P2, PI(3,5)P2, PI(4,5)P2 and PI(3,4,5)P3, whereas PI(4)P and 
PI(4,5)P2 reflect the most abundant forms. Different phosphoinositide classes can be 
regarded as organelle markers since they are predominantly synthesized and located at 
different membranes such as PI(3)P at early endosomes, PI(4)P at the Golgi complex and 
PI(4,5)P2 and PI(3,4,5)P2 at the plasma membrane (Di Paolo and De Camilli, 2006). 
Introduction 
_________________________________________________________________ 
18 
The phosphorylated headgroup of PIPs can bind to effector proteins and thereby trigger 
signaling and activation processes. Several domains have been described to specifically 
interact with different types of PIPs. These domains include pleckstrin homology (PH), 
phagocyte oxidase (PX), epsin N-terminal homology (ENTH), C2 and FYVE zinc finger 
domains (Downes et al., 2005; Di Paolo and De Camilli, 2006). For example, at the trans-
Golgi network (TGN), PI(4)P binds to a variety of proteins such as epsinR, AP-1, FAPP1, 
FAPP2, OSPB and to CERT indicating important functional roles of PIPs in vesicular 
transport (De Matteis et al., 2005). Plasma membrane-located PI(4,5)P2 is involved in a 
plethora of processes such as endo- and exocytosis, plasma membrane cytoskeleton 
interactions and signal transduction (Di Paolo and De Camilli, 2006). TCR-induced 
signaling in activated T cells (Smith-Garvin et al., 2009) comprises, among other things, 
the activation of phospholipase PLCγ1 that specifically cleaves plasma membrane 
anchored PI(4,5)P2, thereby generating the second messenger molecules IP3 and DAG. 
DAG activates two major pathways involving Ras and PKCθ (Carrasco and Merida, 2004). 
The water soluble IP3 stimulates Ca2+-permeable ion channel receptors in the ER, leading 
to Ca2+-release into the cytoplasm. 
 
1.2.2 Glycerolipids 
The family of glycerolipids comprises mainly monoacylglycerols (MAGs), diacylglycerols 
(DAGs) and triacylglycerols (TAGs). Whereas the main function of TAGs is to store 
energy in lipid droplets, MAGs and DAGs are involved in more dynamic cellular processes 
such as lipid synthesis and signaling (Askari et al., 1991; Toker, 2005). 
 
1.2.2.1 Diacylglycerol (DAG) 
DAG (Figure 1) is a low abundant glycerolipid with two fatty acids attached to the sn-1 and 
sn-2 position. The sn-3 position remains in its unmodified, hydroxylated form. De novo 
formation of DAG includes the synthesis of lysophosphatidic acid (LPA) that is acylated to 
PA by LPA acyltransferase (Carrasco and Merida, 2007). PA is then hydrolyzed by a  
PA phosphatase (PAP) (Kocsis and Weselake, 1996) to finally produce DAG. In addition 
to de novo synthesis, three alternative pathways can generate DAG through the action of 
the sphingomyelin synthase and the phospholipases PLD and PLC. The latter 
mechanisms of DAG production results in temporally and spatially increased DAG levels 
that are rather required for signaling events than for metabolic purposes (see chapter 
1.2.1.2).  
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Besides function as lipid intermediate and effector molecule, DAG possesses important 
biophysical properties that can significantly influence the behavior of membranes (Goni 
and Alonso, 1999). Due to its small headgroup, DAG resembles a cone-shaped lipid that 
induces negative curvature in membranes. This property links DAG to processes like 
vesicle formation at the Golgi complex (Fernandez-Ulibarri et al., 2007; Kearns et al., 
1997; Litvak et al., 2005; Asp et al., 2009) and ilimaquinone-induced vesiculation of the 
Golgi complex (Sonoda et al., 2007). 
 
1.2.3 Sphingolipids 
The basic building block of sphingolipids is a sphingoid base. The most common base in 
mammals is sphingosine (1,3-dihydroxy-2-amino-4-octadecene), with a trans-double bond 
between C4 and C5 (Karlsson, 1970; Barenholz and Thompson, 1999). Different kind of 
fatty acids (mainly C16-C24) can be linked via an amid bond to sphingosine to produce 
ceramide (Figure 1). In eukaryotic cells, ceramide is produced at the ER by the ceramide 
synthase (Wang and Merrill, Jr., 2000), which catalyzes the N-acylation of the sphingoid 
base. De novo synthesized ceramide is transported via a non-vesicular pathway by the 
ceramide transport protein CERT (Hanada et al., 2009; Hanada et al., 2007; Hanada, 
2010) to the Golgi where it is further processed to sphingomyelin (SM) (Figure 1). 
Alternatively, ceramide can be produced through the catabolism of SM by the action of 
sphingomyelinases (Goni and Alonso, 2002). Like DAG, ceramide is a cone-shaped 
molecule with a relatively compact headgroup. These properties contribute to curvature 
stress that promotes hexagonal phase formation and membrane trafficking through 
vesiculation and fusion (van Blitterswijk et al., 2003). Furthermore, ceramide can induce 
lipid flip-flop in biological membranes (Contreras et al., 2009) and act as a second 
messenger that activates apoptotic processes (Haimovitz-Friedman et al., 1997). 
 
The synthesis of SM is mediated by the SM synthase (SMS) that transfers the phospho-
choline moiety from PC onto the primary hydroxyl group of ceramide, thus generating SM 
and DAG (Ullman and Radin, 1974; Voelker and Kennedy, 1982). Two SM synthases 
SMS1 and SMS2 are encoded in the mammalian genome catalyzing the SM production 
as Golgi- and PM-associated enzymes (Sadeghlar et al., 2000; Tafesse et al., 2007). 
Molecular differences between glycerophospholipids and sphingolipids become apparent, 
when comparing PC and SM. Although showing a high degree of structural similarity, the 
presence of the hydroxyl- and amide-moiety in SM results in unique biophysical properties 
that are responsible for a high degree of acyl chain ordering and furthermore for the 
formation of intra- and intermolecular hydrogen bonding (Ernst et al., 2010; Mombelli et 
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al., 2003). SM has a high affinity for cholesterol (Veiga et al., 2001), therefore contributing 
to the formation of densely packed, liquid-ordered microdomains (Ramstedt and Slotte, 
2006). 
 
1.2.4 Sterol lipids 
The most prominent sterol is cholesterol (Figure 1). The biosynthesis of cholesterol, 
rewarded with the Nobel Prize in medicine in 1964, is a highly complex series of more 
than thirteen enzymatic reactions (Bloch, 1965). Besides being an important precursor of 
hormone synthesis, one of the main functions of cholesterol is to modulate the fluidity of 
membranes. The structural properties of cholesterol enables both, the induction of local 
order in a fluid phase and the fluidization of lipids in gel phase (Ernst et al., 2010). The 
ability of cholesterol to modulate membrane fluidity can be attributed to its interaction 
potential with neighboring phospholipids and SM (Ramstedt and Slotte, 1999; Halling et 
al., 2008; Ohvo-Rekila et al., 2002). 
 
Figure 1: Chemical structures of lipid classes. The fatty acid composition of a given lipid class is 
indicated by the sum of C atoms and sum of double bonds (Σ C atoms: Σ double bonds). 
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1.3 Heterogeneity of lipid membranes 
A remarkable feature of living cells is that they establish and maintain distinct lipid 
compositions of different membranes such as the PM, the ER, the Golgi complex and 
mitochondria (van Meer, 1989; van Meer et al., 2008). This phenomenon is quite distinct 
along the secretory pathway where a lipid gradient exists between the ER and the PM 
(Schneiter et al., 1999; Fleischer et al., 1974; Zambrano et al., 1975). The PM reflects a 
liquid-ordered membrane with high levels of cholesterol, saturated glycerophospholipids 
and sphingolipids thus promoting bilayer rigidity and impermeability (van Meer et al., 
2008; Holthuis and Levine, 2005). In contrast, the ER contains low amounts of sphingo-
lipids and cholesterol but is highly enriched in unsaturated glycerophospholipids resulting 
in a flexible membrane that facilitates the incorporation of newly synthesized lipids and 
proteins (van Meer et al., 2008; Holthuis and Levine, 2005). The lipid composition of the 
Golgi complex, as a lipid-based sorting station, resembles an intermediate state between 
ER and PM (van Meer, 1998).  
 
Another level of complexity within membranes arises from the fact that lipids are differ-
ently orientated within the bilayer (bilayer asymmetry) (Devaux and Morris, 2004; Op den 
Kamp, 1979). Whereas lipids of the ER membrane are relatively symmetric distributed 
within the bilayer, lipids of the PM are asymmetrically distributed between the two leaflets 
of the membrane with PC, SM and glycosphingolipids (GSLs) preferentially located on the 
luminal side of the leaflet and the aminophospholipids PS and PE concentrated in the 
cytosolic leaflet (Holthuis and Levine, 2005; Sprong et al., 2001).  
 
Lipid heterogeneity also occurs laterally within a bilayer (Devaux and Morris, 2004). 
Lateral heterogeneity exists in polarized epithelial cells where GSLs and PCs are 
differentially localized to apical and basolateral domains, respectively (Simons and van, 
1988; van Meer and Simons, 1988; van Meer et al., 1987). Lipid rafts (Lingwood and 
Simons, 2010; Lingwood et al., 2009) can also be regarded as laterally segregated SM- 
and cholesterol-enriched platforms. Segregation of cholesterol and SM during vesicle 
formation at the Golgi complex (Brugger et al., 2000; Klemm et al., 2009) and the 
enrichment of raft lipids in viral membranes (Brugger et al., 2006) are indications that 
membrane budding events might be restricted to laterally segregated membrane domains. 
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1.4 Lipid transport mechanisms 
The intracellular transport of lipids can be achieved in several ways such as lateral move-
ment, transbilayer movement, monomeric exchange and vesicular transport (Sprong et 
al., 2001; Holthuis and Levine, 2005).  
 
Lateral movement is a rapid process where lipids diffuse in the lateral plane of a bilayer 
with diffusion coefficients that are 10-100-fold higher than those of membrane proteins 
(Holthuis and Levine, 2005). A typical phospholipid can diffuse laterally in a bilayer at a 
rate of several µm/sec, thus one lipid molecule can travel from one end of a cell to the 
other end within a few seconds.  
 
Transbilayer movement (flip-flop) is the exchange of lipids between the two leaflets of a 
bilayer. Lipids can traverse bilayers either in a non-catalyzed fashion or catalyzed by 
enzymes or external agents (Contreras et al., 2010). The non-catalyzed flip-flop is rapid 
(seconds to minutes) for lipids with a small headgroup such as LPC, DAG and ceramide 
(Holthuis and Levine, 2005). In contrast, for lipids with large headgroups (PC and SM) 
non-catalyzed flip-flop can take up to hours or days (Holthuis and Levine, 2005). Several 
enzymes such as flippases, floppases and scramblases greatly enhance the catalyzed 
flip-flop of lipids within a bilayer. For example, the asymmetric distribution of PE and PS at 
the plasma membrane is generated and maintained by the flippase “aminophospholipid 
translocase” (Devaux et al., 1990).  
 
Monomeric exchange is a relevant mode of lipid transport for mitochondria and peroxi-
somes, organelles that are not connected to vesicular transport pathways. This transfer 
can be mediated in a non-catalyzed fashion through the cytosol or at increased rates at 
membrane contact sites (Levine and Loewen, 2006). Additionally, the presence of lipid 
transfer proteins (LTPs) can markedly accelerate the exchange of lipids through the 
cytosol and at membrane contact sites (Lev, 2010).  
 
Vesicular transport of lipids is achieved by selective inclusion or exclusion of certain lipid 
classes during the formation of transport carriers. The Golgi apparatus and vesicles 
derived thereof play important roles in vesicle-mediated transport and sorting of lipids 
(Nickel et al., 1998a; Brugger et al., 2000; Ikonen and Simons, 1998; Klemm et al., 2009).  
For COPI vesicles, it was shown that they contain less cholesterol and SM compared to 
the donor Golgi membrane (Brugger et al., 2000) demonstrating a direct role of COPI 
vesicles in maintaining the lipid gradient along the secretory pathway. A similar role of lipid 
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transport and sorting can be ascribed to TGN-derived secretory vesicles that were found 
to be specifically enriched in SM and cholesterol (Klemm et al., 2009).  
 
1.5 Nano-ESI-MS/MS for lipid quantification 
To study molecular processes that are linked to changes in cellular and intracellular lipid 
levels, sensitive methods for the comprehensive quantification of membrane lipids are 
required. Conventional approaches for lipid analysis employ TLC (Skipski et al., 1964), 
HPLC (Hax and van Kessel, 1977) and gas chromatography mass spectrometry (GC-MS) 
(Figure 2). Nevertheless, these methods are time and sample consuming and, further-
more, show limitations in the resolution of lipid classes and lipid species. 
 
The combination of electrospray ionization (ESI) with (tandem) mass spectrometry was an 
important progress in the field of structural and quantitative lipid analysis (Han and Gross, 
1994; Kerwin et al., 1994). However, ESI alone requires relatively high amounts of starting 
material since lipid extracts are infused at flow rates in the µl/min-range. The replacement 
of the ESI source by a nano-ESI source was an imperative step forward in terms of 
sample consumption, thus allowing the sensitive analysis of lipid extracts at flow rates in 
the nl/min-range (Brugger et al., 1997). Furthermore, nano-ESI in combination with lipid 
class specific precursor and neutral loss scans on a triple quadrupole mass spectrometer 
(Figure 2) enabled the parallel identification and quantification of lipid classes (e.g. PC) 
and lipid species (e.g. PC 34:2) directly from crude lipid mixtures (Brugger et al., 1997). 
Consequently, the concept of shotgun-lipidomics arose (Han and Gross, 2005). 
 
The invention of hybrid tandem mass spectrometers (Figure 2) such as quadrupole time-
of-flight and linear ion trap-Orbitrap instruments, combined with automated nano-ESI 
infusion devices, facilitates high throughput lipidomics analysis by multiple precursor ion 
scanning (MPIS) (Stahlman et al., 2009; Ekroos et al., 2002; Ejsing et al., 2006),  
data dependent acquisition (DDA) (Schwudke et al., 2006; Schwudke et al., 2007b) and 
top-down lipidomics screen (Schwudke et al., 2007a). Such analytical approaches allow 
lipid analysis down to the molecular species level (e.g. PC 16:0/18:2 or PC 16:1/18:1). 
Introduction 
_________________________________________________________________ 
24 
 
Figure 2: The development of quantitative lipid analysis. Taken from Shevchenko and Simons 
2010. 
1.5.1 Nano-ESI-MS/MS for quantification of CL, DAG and PIPs  
The analysis of CL was conventionally performed by HPLC (Schlame and Otten, 1991) 
and has been continuously replaced by quantitative MS techniques. LC-ESI-MS/MS 
facilitates CL quantification by monitoring on singly charged (Sparagna et al., 2005)  
or doubly charged ions (Valianpour et al., 2002; Garrett et al., 2007). Han and Gross went 
a step further and demonstrated the quantification of doubly charged CLs by direct 
infusion ESI-MS/MS employing two-dimensional MS analysis (Han et al., 2006).  
CL quantification by nano-ESI-MS/MS was recently demonstrated by Ejsing et al, who 
quantified doubly charged CLs by multiple precursor ion scanning (MPIS) (Ozcan et al., 
2007) and linear ion Trap-Orbitrap mass spectrometry (Ejsing et al., 2009).  
 
DAG has traditionally been analyzed by the DAG kinase assay (Bielawska et al., 2001)  
or by GC-MS after chemical derivatization (Falardeau et al., 1993; Hubbard et al., 1996). 
ESI-MS/MS can be used for DAG quantification after LC separation (Callender et al., 
2007) or by direct infusion after derivatization (Li et al., 2007b). Quantification of positively 
charged DAG ammonium adducts by nano-ESI-MS/MS was recently demonstrated by 
neutral loss scanning (Murphy et al., 2007) and MPIS (Stahlman et al., 2009).  
Ejsing et al reported the quantification of negatively charged DAG by MPIS (Ejsing et al., 
2009).  
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Due to their extreme low abundance, PIPs are traditionally analyzed by metabolic labeling 
with myo-[3H]-inositol followed by TLC- or LC-analysis (Hama et al., 2004; Bird, 1994; 
Cooke, 2009; Mallo et al., 2008). ESI-MS/MS has been applied for the identification  
(Milne et al., 2005) and structural elucidation of PIPs (Hsu and Turk, 2000). Quantification 
of PIPs can be achieved by ESI-MS/MS after LC separation (Pettitt et al., 2006) or by 
direct infusion of lipid extracts (Wenk et al., 2003). However, there is currently no method 
available that facilitates the quantification of PIPs by nano-ESI-MS/MS. 
 
1.6 Aims of the thesis 
In the first project (collaboration with Prof. Dr. Thomas Langer and Dr. Christof Osman, 
Institute for Genetics, University of Cologne), we planned to investigate how mitochondrial 
phospholipids are affected in the absence of GEP genes (genetic interactors of 
prohibitins). GEP genes comprise a set of genes that were identified in a genome wide 
screen to genetically interact with prohibitins in yeast mitochondria (Osman, 2009; Osman 
et al., 2009). Initial experiments indicated a critical connection between GEP genes and 
mitochondrial lipid composition. We therefore aimed at a quantitative analysis of the 
phospholipids PE and CL in mitochondria derived from yeast cells lacking GEP genes.  
To this end, a method for CL quantification by nano-ESI-MS/MS was established. 
 
Another goal (collaboration with Prof. Dr. Vivek Malhotra and Dr. Josse van Galen, Center 
for Genomic Regulation, Barcelona, Spain) was to determine if the marine sponge 
metabolite ilimaquinone (IQ) affects lipid levels in Golgi membranes. IQ is known to 
induce reversible vesiculation of the Golgi complex (Takizawa et al., 1993). The molecular 
mechanism of this process is still unknown. Previous data indicated that lipids such as 
DAG are required for IQ-induced Golgi fragmentation (Sonoda et al., 2007), however this 
has never been confirmed by quantitative lipid analysis. In order to determine the effect of 
IQ on Golgi membranes, a method for DAG quantification by nano-ESI-MS/MS was 
established.  
 
A further task was to elucidate whether proximal lipid signaling in primary human  
T cells (Tcons) is affected by regulatory T cells (Tregs) (collaboration with Prof. Dr. Peter 
H. Krammer and Angelika Schmidt, DKFZ, Heidelberg). In vitro experiments revealed fast 
kinetics of Tcon suppression in the presence of Tregs (Oberle et al., 2007). The exact 
mechanism of suppression, however, is still unknown. In order to analyze signaling lipids 
in Tcons we planned to set up an approach that facilitates the simultaneous quantification 
of PIP, PIP2 and DAG by nano-ESI-MS/MS. 
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In the final part of this thesis, the question to what extend COPI vesicles are involved in 
intracellular lipid sorting was addressed. Previous experiments showed that SM and 
cholesterol are segregated during the formation of COPI vesicles at the Golgi complex 
(Brugger et al., 2000). An extended lipid analysis of COPI vesicles was planned in order to 
reveal if other lipid classes or species are selectively enriched or reduced in COPI 
vesicles.  
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2 Results 
2.1 Method development 
2.1.1 Quantification of CL 
CL is a dimeric glycerophospholipid that is found in bacteria and mitochondrial mem-
branes of eukaryotic cells. Mitochondrial CL is required to maintain cellular functions such 
as energy production by stabilizing and activating respiratory chain complexes III and IV 
(Pfeiffer et al., 2003). Furthermore, CL has been associated with apoptosis (McMillin and 
Dowhan, 2002) and diseases such as Barth syndrome (Hauff and Hatch, 2006). To study 
cellular mechanisms that are linked to mitochondrial CL, sensitive methods for the 
quantification of CL molecular species are required. In order to develop a method for CL 
quantification by nano-ESI-MS/MS, the mass spectrometric ionization and fragmentation 
behavior of two commercially available CL species was characterized. 
 
2.1.1.1 Mass spectrometric characterization of CL molecular species  
CL 56:0 with the fatty acid composition 14:0/14:0/14:0/14:0 is not detectable in yeast 
mitochondria (Schlame et al., 1993) and was therefore used as an internal standard for 
the quantification of endogenous CL species. Furthermore, CL 72:4 with a typical 
“endogenous-like” fatty acid composition 18:1/18:1/18:1/18:1 was used as reference 
standard to analyze the behavior of endogenous CL species from yeast (Schlame et al., 
1993). Due to two phosphate groups, CL can occur either as singly [M-H]- (Sparagna et 
al., 2005) or doubly charged [M-2H]2- molecule (Valianpour et al., 2002; Han et al., 2006; 
Garrett et al., 2007). Although the quantification of doubly charged CLs from crude lipid 
mixtures was previously demonstrated (Han et al., 2006) we aimed at conditions that 
facilitate the analysis of singly charged CL ions in order to avoid interference with other 
phospholipids such as PE, PA and PG that appear in the same mass range as doubly 
charged CL ions. 
 
To check the ionization behavior of CLs on the mass spectrometric system used in this 
study an equimolar mixture of the two CL species was prepared and analyzed by  
TOF-MS. Analyzing both CL species in pure methanol, doubly charged CL-ions [M-2H]2- 
at m/z 619.42 (CL 56:0) and at m/z 727.51 (CL 72:4) were the sole signals in the spectra 
(Figure 3 A). Notably, after adjusting the solvent system to 5 mM ammonium acetate and 
0.05% piperidine, singly charged ions at m/z 1239.83 (CL 56:0) and at m/z 1456.01  
(CL 72:4) became the prevailing signals (Figure 3 B). The abundance of singly charged 
ions was ~70-80% compared to ~20-30% residual doubly charged ions that were still 
Results 
_________________________________________________________________ 
28 
detectable (Figure 3 B). Irrespective of the charge state, CL 56:0 and CL 72:4 showed 
significant differences in their response behavior indicated by response factors (Rfs)  
(peak intensity ratio CL 56:0 / CL 72:4) of ~1.33 (doubly charged ions) and ~1.66 (singly 
charged ions). 
 
Figure 3: Ionization and fragmentation of CL 56:0 and CL 72:4. (A) TOF-MS spectrum of 
negatively, doubly charged CL 56:0 (m/z 619.42) and CL 72:4 (m/z 727.51) resulting from the 
infusion in methanol. (B) TOF-MS spectrum of negatively, singly charged CL 56:0 (m/z 1239.83) 
and CL 72:4 (m/z 1456.01) resulting from the infusion in 5 mM ammonium acetate and 0.05% 
piperidine in methanol. (C and D) Product ion spectra of CL 56:0 (C) and CL 72:4 (D). The 
glycerolphosphate-H2O fragments (m/z 152.9) and the fatty acid fragments 14:0 (m/z 227.2) and 
18:1 (m/z 281.25) are displayed.  
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Collision-induced dissociation (product ion mode) of singly charged CL ions confirmed the 
identity of the molecular species (Hsu et al., 2005) by the presence of the glycerol-
phosphate-H2O fragment (m/z 152.99) and the fatty acid derived ions at m/z 227.2  
(FA 14:0 of CL 56:0) (Figure 3 C) and at m/z 281.25 (FA 18:1 of CL 72:4), respectively 
(Figure 3 D). 
 
We next wanted to determine the limits of quantification for singly charged CL ions in the 
TOF-MS mode and the product ion mode. To this end, quantification of “endogenous-like” 
CL 72:4 was achieved by the internal standard CL 56:0 whereas the peak intensities of 
the monoisotopic ions (m/z 1239.83 and m/z 1456.01) were used for quantification in the 
TOF-MS mode. The fatty acid ions (m/z 227.2 and m/z 281.25) were taken for 
quantification in the product ion mode. In order to determine optimal dissociation 
conditions for product ion experiments, the dependency of the applied collision energy 
(CE) on the fatty acid signal intensities was investigated (Figure 4). CE ramping ex-
periments revealed that a CE of -85 eV results in most intense signals of the fatty acid 
derived ions. Notably, the signal derived from CL 56:0 (m/z 227.2) gave higher ion counts 
compared to the signal from CL 72:4 (m/z 281.25) at any applied collision energy. This 
effect can be explained in a way that the smaller molecular size of CL 56:0 results in a 
more efficient dissociation compared to CL 72:4. For compensation of this discrepancy,  
a Rf (peak area fatty acid 14:0 / peak area fatty acid 18:1) of 1.5 ± 0.1 (n=4) was 
determined. 
 
Figure 4: Fragmentation efficiency of CL 56:0 and CL 72:4 at different CEs. Fatty acid peak area 
intensities at different collision energies are displayed for CL 56:0 and CL 72:4. Data represent 
mean ± average deviation of three independent experiments.  
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The limits of quantification for TOF-MS and the product ion mode were investigated by 
analyzing a dilution series of CL 72:4 quantified by fixed amounts of CL 56:0. Differences 
in signal intensities between both CL species were corrected by applying Rfs of 1.66 
(TOF-MS mode) and 1.5 (product ion mode). As show in Figure 5, no significant 
differences between both analytical approaches were observed when CL 72:4 was 
quantified at concentration levels from 10 nM to >100 nM. Within this range, CL 72:4 
could be linearly quantified in both modes. However, when the concentration of CL 72:4 
reached levels <10 nM, quantification in the TOF-MS mode was not possible anymore. 
Due to noise peaks, very low amounts of CL 72:4 were not distinguishable from back-
ground peaks, leading to apparent higher amounts. Noticeably, in the product ion mode, 
CL 72:4 could be linearly quantified down to concentration levels of ~1 nM, indicating an 
extended dynamic range towards lower concentrations. 
 
Figure 5: Limit of CL quantification. CL 72:4 was titrated over the indicated concentration range and 
quantified by fixed amounts of the internal standard CL 56:0. Mass spectrometric analysis was 
performed by TOF-MS and in the product ion mode. Data represent mean ± average deviation of 
three independent experiments. 
2.1.1.2 CL quantification in the presence of mitochondrial lipid extracts 
In order to ensure robust and accurate quantification of endogenous CL species in 
mitochondrial lipid extracts, the influence of mitochondrial lipid background on the 
quantification of CL 72:4 was tested. For this purpose, mitochondria were isolated from 
∆crd1 yeast mutants that cannot synthesize CL due to the absence of the cardiolipin 
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synthase Crd1 (Chang et al., 1998b; Jiang et al., 1997). A dilution series of CL 72:4 was 
prepared and spiked together with a fixed proportion of CL 56:0 (50 pmol) into constant 
amounts of ∆crd1 mitochondria (~1 nmol phospholipids). After lipid extraction, CL 72:4 
was quantified in the product ion mode by the internal standard CL 56:0. As depicted in  
Figure 6, quantification of CL 72:4 was linear over a broad range of analyzed CL amounts 
clearly indicating that the lipid background of mitochondrial preparations did not influence 
the quantification of singly charged CL in the product ion mode. 
 
Figure 6: CL quantification in the presence of mitochondrial lipid extracts. Different amounts of  
CL 72:4 were spiked into mitochondrial fractions derived from ∆crd1 yeast cells. After spiking a 
fixed amount of the internal standard CL 56:0, lipids were extracted and CL 72:4 was quantified in 
the product ion mode. Data represent mean ± average deviation of two independent experiments. 
2.1.1.3 Identification and quantification of CL in yeast mitochondria  
In order to demonstrate that endogenous CL species can be identified and quantified by 
product ion analysis of singly charged CL ions, mitochondrial fractions were isolated from 
wt and taffazin knock out yeast cells (∆taz1) and lipid extracts were investigated with 
respect to CL. Taz1 has been described as a putative transacylase involved in fatty acid 
remodeling of CL (Xu et al., 2006; Malhotra et al., 2009; Xu et al., 2003). In particular, 
taffazin is responsible for the attachment of unsaturated fatty acids onto monolyso-
cardiolipin (MLCL) in order to generate a “mature” CL pool with a high degree of 
unsaturated, symmetric CL species (Schlame et al., 2005). In the absence of taffazin, 
mitochondria exhibit an aberrant CL species profile with a higher degree of saturated 
species as compared to the wt profile (Gu et al., 2004; Li et al., 2007a). 
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For quantification of mitochondrial CL, product ion analysis of putative, endogenous CL 
species was performed (Table 1). The list covers 45 different CL species with all possible 
combinations of the fatty acids 16:0, 16:1, 16:2, 18:0, 18:1 and 18:2 which were previously 
identified in yeast cells (Schneiter et al., 1999) and yeast mitochondrial fractions (Schlame 
et al., 1993). To ensure correct quantification of molecular species, the isotopic con-
tribution of signals derived from neighboring CL species was compensated by correction 
for isotopic overlap (data not shown). Furthermore, the experimentally determined 
response factor of 1.5 (see chapter 2.1.1.1) was used to correct for response differences 
between the internal standard CL 56:0 and endogenous CL species. To increase the 
specificity of CL species identification, a threshold was applied to the data set. Only 
species accounting for >0.5 mol% of the 45 analyzed precursors were considered to be 
unambiguously identified as CL. 
 
Table 1: Putative CL species of yeast mitochondria. The list represents CL species (all 
combinations of the fatty acids 16:0, 16:1, 16:2, 18:0, 18:1 and 18:2) that were used for CL 
quantification by product ion analysis. Molecular species are indicated by their fatty acid 
composition (species), the theoretical m/z of singly charged CL ions [M-H]- and possible fatty acid 
combinations.  
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Product ion analysis of putative CL precursor ions enabled the identification and 
quantification of 28 molecular CL species in wt and ∆taz1 mitochondria (Figure 7 A). As 
expected, the CL species profile of wt mitochondria reflected a rather symmetric dis-
tribution with a high degree of monounsaturated fatty acids (Schlame et al., 2005). The 
most prominent CL species were found to be CL 66:4, CL 68:4 and CL 70:4. In contrast, 
the species pattern in ∆taz1 mitochondria showed an altered profile, characterized by 
significant reduced levels of unsaturated species, such as CL 64:4, CL 66:4, CL 68:7,  
CL 68:4, CL 70:7 and CL 70:4, which was compensated by elevated levels of species with 
a higher degree of saturation such as CL 66:3, CL 66:2, CL 68:3 and CL 68:2. 
 
Figure 7: Identification and quantification of endogenous CL species. (A) Phospholipids of wt and 
∆taz1 mitochondrial fractions were extracted in the presence of the internal standard CL 56:0 and 
analyzed by product ion analysis of CL precursors (Table 1). Endogenous CL species were 
quantified via the corresponding fatty acid fragments. Data represent mean ± average deviation of 
two independent experiments. (B) Distribution of fatty acids derived from CL species identified in wt 
and ∆taz1 mitochondria.  
Results 
_________________________________________________________________ 
34 
The fatty acid distribution, as depicted in Figure 7 B, revealed that the saturated fatty 
acids 16:0 and 18:0 were specifically enriched in ∆taz1 mitochondria whereas the un-
saturated fatty acids 16:1, 18:1 and 18:2 were reduced compared to the wt situation. 
Interestingly, the most prominent effect occurred on the level of the fatty acid 16:0 which 
was ~1.8-fold increased in ∆taz1 mitochondria. 
 
Consistent with previous observations (Daum and Vance, 1997), the basal level of all 28 
identified CL species in wt mitochondria was quantified to ~15 mol% (Figure 8). CL level 
in ∆taz1 mitochondria were slightly reduced, accounting to ~12 mol% of phospholipids 
(Figure 8). 
 
Figure 8: Quantification of phospholipids in wt and ∆taz1 mitochondria. Phospholipids were 
extracted in the presence of internal lipid standards. For CL quantification, lipid extracts were 
analyzed by product ion analysis of CL precursors (Table 1). Endogenous CL was quantified via 
the corresponding fatty acid fragments. Quantification of other lipid classes was done as described 
in materials and methods. Data represent mean ± average deviation of two independent 
experiments. 
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2.1.2 Quantification of DAG  
DAG is a low abundant but highly important lipid molecule of biological membranes that 
has been associated with cellular processes such as protein recruitment and activation 
(Carrasco and Merida, 2004), signaling (Toker, 2005) and vesicular trafficking 
(Fernandez-Ulibarri et al., 2007; Kearns et al., 1997; Litvak et al., 2005). To analyze 
molecular processes that are intimately linked to changes in the level of DAG, applicable 
methods for their absolute quantification are required. We therefore aimed at the 
development of a method that allows the identification and quantification of DAG by nano-
ESI-MS/MS. To this end, a commercially available DAG species was characterized with 
respect to its mass spectrometric ionization and fragmentation behavior. 
 
2.1.2.1 Mass spectrometric characterization of DAG molecular species  
For glycerolipids such as DAG and TAG it has previously been shown that they form 
positively charged ammonium adducts when analyzed by atmospheric pressure chemical 
ionization (APCI) (Mu and Hoy, 2000) and nano-ESI (Schwudke et al., 2006; Murphy et 
al., 2007). To analyze the ionization and fragmentation behavior of DAG on our system a 
commercially available DAG species with the fatty acid composition 16:0/18:1 (DAG 34:1) 
was analyzed in the presence of ammonium acetate. In the TOF-MS mode, DAG 34:1 
showed a prominent peak at m/z 612.57 corresponding to its ammoniated form  
(Figure 9 A). Collision-induced dissociation (product ion analysis) of the precursor at  
m/z 612.57 resulted in a fragment pattern typically observed for DAGs (Murphy et al., 
2007) (Figure 9 B). Four characteristic fragment ions were detected at m/z 595.54,  
m/z 577.53, m/z 339.3 and m/z 313.28. The fragment at m/z 577.53 resulted from the 
dissociation of H2O + NH3 leading to a characteristic neutral loss of 35 Da (NL 35) 
(Murphy et al., 2007). The fragments at m/z 313.28 and m/z 339.3 reflected neutral losses 
of the fatty acids 16:0 and 18:1 together with ammonia (RCOOH + NH3) (Murphy et al., 
2007) leading to positively charged ions that represent monoacylglycerol-H2O fragments 
MAG-H2O 16:0 and MAG-H2O 18:1. In contrast to previous observations (Murphy et al., 
2007) a weak loss of deprotonated ammonia (neutral loss of 17 Da) was detected leading 
to a protonated DAG molecule at m/z 595.54. Nevertheless, the presence of this ion 
depends on the collision energy (CE) since it disappeared at higher CE offsets (data not 
shown). 
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Figure 9: Ionization and fragmentation of DAG. (A) Detection of DAG 34:1 (16:0/18:1) as positively 
charged ammonium adduct in the TOF-MS mode. (B) Product ion analysis of DAG 34:1 confirmed 
the typical fragmentation pattern of DAGs. Lipid class specific neutral losses and MAG-H2O 
fragments are displayed.  
To achieve optimal dissociation conditions for MS/MS experiments the dependence of the 
collision energy on the intensities of MAG-H20 and NL 35 fragments was investigated. To 
cover a broad range of molecular species, commercially available DAGs with the fatty acid 
composition 14:0/14:0 (DAG 28:0), 16:0/16:0 (DAG 32:0), 16:0/18:1 (DAG 34:1), 
17:0/17:0 (DAG 34:0), 18:1/18:1 (DAG 36:2) and 18:0/20:4 (DAG 38:4) were analyzed by 
product ion analysis. For every species, the CE was ramped from 5 to 55 eV and the peak 
intensities of MAG-H2O and NL 35 fragments were monitored (Figure 10 A-F). All DAG 
species showed a similar correlation between the CE and the intensities of the MAG-H2O 
fragments, whereas a CE of 25 eV resulted in most intense signals. In contrast, for NL 35 
fragments the dissociation efficiency varied depending on the fatty acid composition of the 
parent molecule. Whereas for DAG 28:0 and DAG 32:0 a CE of 15 eV resulted in most 
intense NL 35 derived fragments, species with longer fatty acid chains such as DAG 34:1, 
34:0, 36:2 and 38:4 required a CE of 25 eV for optimal dissociation. In general, NL 35 
derived fragments displayed lower peak intensities compared to the MAG-H2O ions. 
However, DAG 38:4 with the polyunsaturated fatty acid 20:4 exhibited a drastic, ~8-fold 
lower intensity of the NL 35 derived fragment (Figure 10 F). This characteristic 
fragmentation behavior did not allow a sensitive analysis of DAG 38:4 by neutral loss 
scanning for 35 Da (data not shown). In contrast, MAG-H2O ions showed comparable 
peak intensities of all analyzed DAG species, thus making MAG-H2O fragments the 
preferential ions to scan for in MS/MS experiments.  
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Figure 10: Fragmentation efficiency of DAG molecular species at different CEs. Peak areas of  
NL 35 and MAG-H20 fragments are displayed for the indicated CE. For asymmetric DAG species, 
the peak area sum of two MAG-H2O fragments is displayed. Data represent mean values ± 
average deviation of two experiments. 
2.1.2.2 Identification and quantification of DAG by MPIS 
Multiple precursor ion scanning (MPIS) was successfully developed for the identification 
and quantification of glycerophospholipids by quadrupole time-of-flight mass spectrometry 
(Ekroos et al., 2002; Ejsing et al., 2006). In comparison to conventional precursor ion and 
neutral loss scanning on triple quadrupole instruments, the non-scanning TOF-analyzer 
allows the acquisition of a virtually unlimited number of precursor ion scans at the same 
time. This feature was used to perform MPIS of a set of negatively charged fragment ions 
that are characteristic for glycerophospholipids. The software tool Lipid Profiler (currently 
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LipidViewTM) was developed to cope with MPIS data by comparing MPIS spectra with lipid 
class specific fragment ions that are stored in a database. Furthermore, the software 
automatically corrects for isotopic overlap, thus enabling the accurate quantification of 
lipid classes and lipid species from complex lipid mixtures. Besides being applicable for 
the identification and quantification of glycerophospholipids, the Lipid Profiler software has 
also been used for the evaluation of MPIS spectra derived from DAGs and TAGs 
(Stahlman et al., 2009). 
 
Similar as described (Stahlman et al., 2009), MPIS of 18 DAG-derived MAG-H2O 
fragments, that are stored in the Lipid Profiler database (Table 2), was performed in order 
to facilitate the identification and quantification of endogenous DAG species. To test this 
approach, an equimolar mixture of commercially available reference standards with the 
fatty acid composition 14:0/14:0 (DAG 28:0), 16:0/16:0 (DAG 32:0), 16:0/18:1 (DAG 34:1), 
18:1/18:1 (DAG 36:2) and 18:0/20:4 (DAG 38:4) was analyzed by MPIS together with 
DAG 17:0/17:0 (34:0) as internal standard. Lipid species with an odd numbered fatty acid 
composition have been demonstrated to be distinguishable from endogenous species by 
MPIS and can therefore serve as internal standards (Ejsing et al., 2006). 
 
Table 2: DAG-specific MAG-H20 fragments used for MPIS. The fragments were taken from the 
Lipid Profiler database. 
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As depicted in Figure 11 A-F, MPIS allowed the simultaneous identification of DAG 
species indicated by positively charged DAG parent ions that were detected by the 
corresponding precursor ion scan for MAG-H2O ions. Symmetric species such as DAG 
28:0 (14:0/14:0), DAG 34:0 (17:0/17:0) and DAG 36:2 (18:1/18:1) were detected in one 
precursor ion scan. In contrast, asymmetric species such as DAG 34:1 (16:0/18:1) and 
DAG 38:4 (18:0/20:4) were detected in two different scans. 
 
Figure 11: Identification of DAG by MPIS. Six DAG molecular species were prepared in equimolar 
amounts and analyzed by MPIS for DAG-specific MAG-H2O fragments (Table 2). Precursor peaks 
represent positively charged DAG ammonium adducts. 
In order to determine response factors (Rfs), DAG reference standards were prepared in 
different quantities (1-20 pmol) and analyzed together with a constant amount (20 pmol) of 
the internal standard DAG 34:0 (17:0/17:0) by MPIS. As shown in Table 3, the Rf-values 
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of all DAG species, except DAG 38:4, were close to 1 with a maximum deviation of about 
10% for DAG 28:0 and DAG 32:0. DAG 38:4 was underestimated ~1.7-fold compared to 
other species. 
 
Table 3: Response factors of the internal standard DAG 34:0 (17:0/17:0). Quantification was 
achieved by MPIS for DAG-specific MAG-H2O fragments (Table 2). Data evaluation was done with 
the Lipid Profiler software. 
2.1.2.3 Identification and quantification of DAG in Golgi membranes 
All experiments so far were performed in a minimal system consisting of defined DAG 
species, i.e. in the absence of potentially interfering lipid classes. When analyzing crude 
lipid extracts such as Golgi membranes, it has to be excluded that structurally similar 
lipids such as TAGs interfere with DAG-specific precursor ion scans. It was reported 
previously that TAGs display DAG-characteristic MAG-H2O fragments upon collision-
induced dissociation (Mu and Hoy, 2000). We therefore tested the fragmentation behavior 
of TAGs on the nano-ESI-MS/MS system used in this study. Notably, we found that TAGs 
did not display DAG-characteristic MAG-H2O fragments (data not shown), thus the 
established MPIS method was suitable for the quantification of DAG in crude lipid 
extracts, unaffected by TAG cross-fragmentation.  
 
Subsequently, MPIS was applied to identify and quantify endogenous DAG in Golgi 
membranes isolated from HeLa cells. To define the minimum amount of Golgi membranes 
needed for robust DAG quantification, increasing amounts of Golgi lipid extracts (0.07-15 
µg protein) were analyzed by MPIS and DAG levels quantified by the internal standard  
DAG 34:0 (17:0/17:0). As depicted in Figure 12, DAG quantification showed a linear 
correlation between ~1-15 µg Golgi protein. In the linear range, the DAG basal level in the 
Golgi was quantified to ~80-90 pmol/µg protein. Assuming a protein/phospholipid ratio of 
~1.2 in the Golgi, this reflects DAG amounts of ~7.6 mol% of phospholipids. In contrast, at 
protein amounts <1 µg the DAG content was misleadingly overestimated reaching a 
plateau between 160-500 pmol/µg protein (Figure 12). Taken together, optimal amounts of 
Golgi membranes that facilitate accurate DAG quantification were found to be in the range 
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of ~1-15 µg protein. Within the linear range, 9 DAG species were identified in Golgi mem-
branes with the major species being DAG 32:0 and DAG 34:1 followed by less abundant 
DAG 30:0, DAG 32:1, DAG 34:0, DAG 34:2, DAG 36:0, DAG 36:1 and DAG 36:2  
(Figure 13). 
 
Figure 12: Dynamic range of Golgi DAG quantification. Quantification was done by MPIS for DAG-
specific MAG-H2O fragments (Table 2). Data evaluation was performed with the Lipid Profiler 
software. Data represents mean values ± average deviation of two independent extractions.  
 
Figure 13: DAG species in Golgi membranes derived from HeLa cells. Identification and 
quantification was done by MPIS for DAG-specific MAG-H2O fragments (Table 2). Data evaluation 
was performed with the Lipid Profiler software. Data represents mean values ± average deviation 
of five independent extractions each analyzed in duplicate.  
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Although DAG was unambiguously identified and quantified in Golgi membranes derived 
from HeLa cells, the observed amounts (80-90 pmol/µg protein) were more than 100-fold 
higher compared to published data (0.55 pmol/µg protein) (Fernandez-Ulibarri et al., 
2007). To solve these discrepancies, the DAG level in several Golgi fractions prepared 
from rat liver, HeLa or CHO cells were systematically analyzed by MPIS. Noticeable, the 
DAG quantities in the different Golgi preparations were quite variable, ranging from  
5-75 pmol DAG/µg protein which corresponds to ~0.5-7 mol% DAG of phospholipids (data 
not shown). Nevertheless, even the lowest amount determined (5 pmol/µg protein) was 
still ~10-fold higher compared to the amount published (0.55 pmol/µg protein) (Fernandez-
Ulibarri et al., 2007). To further exclude that the mass spectrometric method over-
estimated the DAG contents, Golgi DAG was quantified by an independent assay, the 
DAG kinase assay (Bielawska et al., 2001). DAG kinase-based quantification was 
performed by Dr. Inés Fernández-Ulibarri (Research Group: Prof. Dr. Gustavo Egea, 
Barcelona, Spain) and revealed DAG amounts between ~80-100 pmol/µg protein in Golgi 
fractions derived from HeLa cells (data not shown). In conclusion, no significant 
differences were found between the mass spectrometric data and the results obtained by 
the DAG kinase assay, indicating that the mass spectrometric method produced valid 
data.  
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2.1.3 Quantification of PIP and PIP2  
The phosphoinositides PIP and PIP2 (PIPs) are low abundant but highly important lipid 
classes of biological membranes that have been associated with cellular processes such 
as signaling, regulation of membrane traffic, nuclear events and permeability and 
transport functions of membranes (Di Paolo and De Camilli, 2006). To analyze molecular 
processes that are intimately linked to changes in the level of PIPs, methods for their 
identification and quantification are required. We therefore aimed at the development of 
an approach that allows the quantification of PIPs by nano-ESI-MS/MS. HeLa cells were 
taken as a model system to investigate (i) the extraction behavior of endogenous PIPs 
and (ii) identify and quantify molecular PIP and PIP2 species. Furthermore, commercially 
available standards were used to characterize the ionization and fragmentation behavior 
of PIP and PIP2 in order to set up lipid class specific scans that allow the mass 
spectrometric analysis.  
 
2.1.3.1 Extraction behavior of endogenous PIP and PIP2 in HeLa cells 
Due to their polar headgroups, PIPs cannot be sufficiently recovered from biological 
membranes by conventional extraction procedures such as Folch (Folch et al., 1957) or 
Bligh and Dyer (Bligh and Dyer, 1959). Therefore, modified extraction protocols were 
introduced decades ago (Dawson and Eichberg, 1965) and continuously optimized and 
applied for the analysis of PIPs (Michell et al., 1970; Hama et al., 2000; Vickers, 1995; 
Milne et al., 2005; Pettitt et al., 2006; Wenk et al., 2003; Gray et al., 2003). To make PIPs 
accessible for mass spectrometric analysis, a previously described two-step extraction 
procedure for the selective enrichment of PIP and PIP2 was performed (Gray et al., 2003). 
During the first extraction, the cell membrane is depleted from relatively apolar lipids by 
extracting with a mixture of chloroform/methanol (neutral extraction). Finally, negatively 
charged PIPs, which reside in the membrane during the neutral extraction, are recovered 
by an acidic extraction using a mixture of chloroform/methanol/HCl.  
 
To determine the extraction behavior of endogenous PIPs, HeLa cells were labeled with 
myo-[3H]-inositol and subjected to a two-step lipid extraction. 3H-inositiol labeled lipids in 
neutral and the acidic extracts were separated by TLC and visualized by autoradiography. 
The autoradiogram in Figure 14 A shows the distribution of 3H-PI, 3H-PIP and 3H-PIP2 
between the neutral and the acidic extract. Whereas most of 3H-PI was recovered with the 
neutral extraction, the phosphoinositides 3H-PIP and 3H-PIP2 were predominantly present 
in the acidic extract. Quantification of the spot intensities revealed that PI was recovered 
with ~16% in the acidic extract, whereas PIP and PIP2 were enriched with ~58% and 
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~79% in the acidic extract, respectively (Figure 14 B). Taken together, the labeling ex-
periments demonstrated that the two-step extraction provides an easy and fast approach 
to selectively enrich endogenous PIPs from cellular membranes. 
 
 
Figure 14: Extraction recovery of endogenous PIPs. HeLa cells were metabolically labeled with 
myo-[3H]-inositol. After two-step lipid extraction, 3H-labeled inositol lipids were separated by TLC 
and visualized by autoradiography. (A) Autoradiogram showing the distribution of 3H-PI and 3H-
PIPs between neutral and acidic lipid extracts. (B) Quantification of the distribution of 3H-PI and 3H-
PIPs in neutral and acidic extracts. Data represent mean values ± average deviation of four 
independent experiments. Note: the spot intensities in the autoradiogram (A) reflect only a 
proportion of the absolute radioactivity in neutral and acidic extracts. To avoid saturation of the 
detector, maximal 200 nCi were spotted prior TLC separation. For quantification (B), the spot 
intensities were extrapolated to determine the absolute amounts of PI and PIPs in lipid extracts. 
2.1.3.2 Mass spectrometric characterization of PIP and PIP2 molecular 
species
 
 
To set up a method for the mass spectrometric analysis of PIP and PIP2, the ionization 
and fragmentation behavior of two commercially available internal standards, PI(4)P and 
PI(4,5)P2 both with the fatty acid composition 17:0/20:4 (37:4) was investigated. When 
analyzing in positive ion mode in the presence of 25 mM ammonium acetate in 
chloroform/methanol/H2O (1:1:0.05), PI(4)P 37:4 and PI(4,5)P2 37:4 showed distinct  
TOF-MS signals at m/z 970.5 (Figure 15 A) and at m/z 1050.5 (Figure 15 B), respectively. 
The mass differences of 17 Da compared to the calculated, nominal masses of  
m/z 953.51 for PI(4)P 37:4 and m/z 1033.48 for PI(4,5)P2 37:4 indicated that both 
molecules appeared as ammonium adducts (+NH3). Collision-induced dissociation 
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(product ion mode) resulted in the formation of two prominent fragments for PIP and PIP2, 
respectively (Figure 15 C and D). The fragment ions at m/z 953.5 and m/z 613.5 in the 
product ion spectra of PI(4)P 37:4 (Figure 15 C) corresponded to neutral losses of 
ammonia (17 Da) and inositoldiphosphate+NH3 (357 Da). PI(4,5)P2 37:4 showed a similar 
fragmentation pattern resulting in ions at m/z 1033.46 (neutral loss of ammonia) and  
m/z 613.5 corresponding to the neutral loss of inositoltriphosphate+NH3 (437 Da)  
(Figure 15 D). 
 
Figure 15: Ionization and fragmentation of PIPs. Detection of PI(4)P 37:4 (A) and PI(4,5)P2 37:4 (B) 
as positively charged ammonium adducts in the TOF-MS mode. Product ion analysis of PI(4)P 37:4 
(C) and PI(4,5)P2 37:4 (D). Characteristic neutral losses of inositoldiphosphate+NH3 (357 Da) and 
inositoltriphosphate+NH3 (437 Da) are indicated. 
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To determine optimum dissociation conditions for MS/MS experiments the dependency of 
the applied collision energy (CE) on neutral loss derived signals at m/z 613.5 was in-
vestigated for both species. As depicted in Figure 16, PI(4)P 37:4 required a relatively low 
CE of 25 eV for efficient neutral loss of the headgroup fragment (357 Da). In contrast, 
PI(4,5)P2 37:4 with one additional phosphate group required a CE of 35 eV for efficient 
neutral loss of the headgroup fragment (437 Da). 
 
Figure 16: Fragmentation efficiency of PI(4)P 37:4 and PI(4,5)P2 37:4 at different CEs. The peak 
intensities of neutral loss derived fragments (m/z 613.5) were normalized to the peak intensity at 
the optimal collision energy (100% relative intensity). Data represent mean values ± average 
deviation of two experiments. 
2.1.3.3 Identification and quantification of PIP and PIP2 by neutral loss 
scanning 
To investigate endogenous PIPs by neutral loss scanning, commercially available bovine 
brain PI(4)P and bovine brain PI(4,5)P2 were extracted together with the internal 
standards PI(4)P 37:4 and PI(4,5)P2 37:4 and analyzed by scanning for neutral losses of 
357 Da and 437 Da, respectively (Figure 17). Remarkably, neutral loss scanning enabled 
the identification of PIP and PIP2 molecular species, indicated by characteristic profiles of 
brain PI(4)P (Figure 17 A) and brain PI(4,5)P2 (Figure 17 B). Collectively, 16 molecular 
species of bovine brain derived PIPs were unambiguously identified and quantified by 
neutral loss scanning (Table 4). 
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Figure 17: Identification of brain PI(4)P and brain PI(4,5)P2 species. (A) Characteristic PI(4)P brain 
profile acquired by scanning for neutral losses of 357 Da. (B) Characteristic PI(4,5)P2 brain profile 
acquired by scanning for neutral losses of 437 Da. 
 
Table 4: PI(4)P and PI(4,5)P2 species identified in bovine brain. The species are indicated by their 
fatty acid composition, their m/z values (NH4+) and their relative abundances in mol%. Data 
represent mean values ± average deviation of three independent analyses. 
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To determine response factors (Rfs) between the internal standards and endogenous 
reference PIPs, different amounts of bovine brain PI(4)P (~50-200 pmol) and PI(4,5)P2 
(~250-1000 pmol) were mixed with constant amounts of PI(4)P 37:4 (~20 pmol) and 
PI(4,5)P2 37:4 (~210 pmol). After acidic lipid extraction, the extracts were analyzed by 
neutral loss scanning on two different triple quadrupole instruments and by product ion 
analysis of dedicated PIP and PIP2 species (Table 4) on a quadrupole time-of-flight 
instrument. Quantification of bovine brain PIPs resulted in comparable Rfs on all 
instruments (Table 5). For the internal standard PI(4)P 37:4, a Rf of ~1.1 was determined, 
indicating that endogenous PI(4)P brain species were slightly underestimated. In contrast, 
quantification of brain PI(4,5)P2 species was slightly overestimated, indicated by  
Rf values <1. 
 
Table 5: Response factors of internal standards PI(4)P 37:4 and PI(4,5)P2 37:4. Rfs were 
determined by quantification of endogenous PI(4)P and PI(4,5)P2 derived from bovine brain. Data 
represent mean values ± average deviation of the indicated number of experiments.  
2.1.3.4 Identification and quantification of PIP and PIP2 in HeLa cells 
We next aimed at the identification and quantification of endogenous PIPs in HeLa cells. 
To this end, HeLa cells were grown to 80-90% confluency and lipids were extracted by a 
two-step extraction (see chapter 2.1.3.1). For quantification, the internal standards  
PI(4)P 37:4 and PI(4,5)P2 37:4 were spiked in defined amounts (50-200 pmol) to the cell 
sample after the neutral extraction. After acidic extraction, the lipid extract was analyzed 
by scanning for neutral losses of 357 Da and 437 Da in order to identify and quantify HeLa 
PIP and PIP2 (Figure 18). Remarkably, neutral loss scanning enabled the identification of 
PIP and PIP2 molecular species in acidic lipid extracts from HeLa cells indicated by 
characteristic profiles of HeLa PIP (Figure 18 A) and HeLa PIP2 (Figure 18 B). 
Collectively, 18 different PIP and PIP2 molecular species were unambiguously identified in 
the neutral loss spectra (Table 6).  
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Figure 18: Identification of PIP and PIP2 species in HeLa cells. (A) Characteristic PIP profile 
acquired by scanning for neutral losses of 357 Da. (B) Characteristic PIP2 profile acquired by 
scanning for neutral losses of 437 Da. 
 
Table 6: PIP and PIP2 species identified in HeLa cells. The species are indicated by their fatty acid 
composition, their masses (NH4+) and their relative abundances in mol%. Data represent mean 
values ± average deviation of six independent analyses. 
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For absolute quantification of PIP and PIP2 basal level in HeLa cells the raw pmol-values 
were adjusted to correct for (i) losses during the neutral extraction (Figure 14) and  
(ii) response differences between endogenous PIPs and internal standards (Table 5). To 
compensate for losses during the neutral extraction, the data was multiplied by a factor of 
1.72 for PIP (compensates for a loss of 42%) and by a factor of 1.27 for PIP2 
(compensates for a loss of 21%). The data was then multiplied with the response factors 
1.14 for PIP and 0.85 for PIP2. Thus, the absolute amount of PIP in HeLa cells was 
quantified to 0.34 ± 0.02 mol% of phospholipids (n=6). PIP2 was quantified slightly higher 
to 0.49 ± 0.09 mol% of phospholipids (n=6). The amounts were in agreement with 
previous reports (Mallo et al., 2008). 
 
Results 
_________________________________________________________________ 
51 
2.2 Method application 
2.2.1 Genetic interactors of prohibitins regulate mitochondrial PE and CL 
Genetic interactors of prohibitins (GEP genes) comprise a set of 35 yeast genes that were 
identified by Dr. Christof Osman (Research Group: Prof. Dr. Thomas Langer, Institute for 
Genetics, University of Cologne)  in a genome wide screen to genetically interact with 
prohibitins (Osman et al., 2009). Prohibitins are an evolutionary conserved and 
ubiquitously expressed family of membrane proteins that are essential for cell develop-
ment in higher eukaryotes. Prohibitins form large ring complexes in inner mitochondrial 
membranes (Back et al., 2002; Tatsuta et al., 2005) and are involved in mitochondrial 
processes such as cell proliferation, apoptosis and cristae morphogenesis (Merkwirth et 
al., 2008; Merkwirth and Langer, 2009a). The molecular mechanisms of prohibitin function 
and, furthermore, a putative link between prohibitins and mitochondrial lipid homeostasis 
remained elusive. We aimed at a quantitative analysis of CL in mitochondria derived from 
GEP mutant cells to figure out whether GEP genes are involved in the regulation of 
mitochondrial CL. Furthermore, PE, another important mitochondrial lipid class that shares 
the ability to form non-bilayer structures with CL, was taken into account for quantitative 
lipid analysis. 
 
2.2.1.1 Gep1 and Ups1 regulate the level of mitochondrial PE and CL 
Gep1 and Ups1 comprise a set of proteins that were identified in a genome wide screen to 
genetically interact with prohibitins (Osman et al., 2009; Osman, 2009). Since the 
synthetic lethality of ∆phb1∆gep1 cells could be rescued by overexpression of CHO1, a 
first link between these proteins and the homeostasis of mitochondrial phospholipid 
composition was assigned to Gep1 (data not shown) (Osman et al., 2009). CHO1 
encodes for the PS synthase Cho1 which produces PS, the biosynthetic precursor of 
mitochondrial PE. Initial lipid analysis, performed by Dr. Christof Osman, revealed that 
mitochondria from ∆gep1 cells displayed reduced PE levels which were restored upon 
overexpression of CHO1 (data not shown) (Osman et al., 2009). Within the array of 
genetic interactors, two other proteins, Ups1 and Gep2 showed high sequence similarities 
to Gep1 indicating that these genes could also be involved in the regulation of 
mitochondrial lipid levels.  
 
To further investigate how Gep1, Ups1 and Gep2 affect the composition of mitochondrial 
CL and PE, quantitative lipid analysis of mitochondria isolated from ∆gep1, ∆ups1 and 
∆gep2 yeast cells was performed (Figure 19 A and B). As expected from initial TLC 
experiments, the PE level in ∆gep1 mitochondria was strongly reduced, whereas the CL 
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level remained unaffected in the absence of Gep1. In contrast to GEP1, deletion of GEP2 
and UPS1 did not affect PE levels within mitochondria. However, the lipid analysis 
revealed a critical role of Ups1 for the regulation of CL levels, since CL was decreased  
~7-fold in ∆ups1 mitochondria but remained unaffected in the absence of Gep1 or Gep2. 
This data indicates that the accumulation of CL in mitochondria depends on Ups1, 
whereas Gep1 affects mitochondrial PE level. In contrast, Gep2 does not affect the levels 
of mitochondrial PE and CL. Notably, deletion of GEP1 together with UPS1 (∆gep1∆ups1) 
resulted in elevated CL levels compared to ∆ups1 mitochondria. PE remained reduced in 
∆gep1∆ups1 mitochondria, demonstrating that the absence of Ups1 does not alleviate the 
requirement of Gep1 in regulating PE. 
 
Figure 19: Gep1 and Ups1 affect mitochondrial levels of PE and CL. (A and B) Quantification of PE 
and CL in mitochondria lacking Gep1, Ups1 and Gep2. Phospholipids were extracted from 
mitochondria and analyzed by TLC (A) and mass spectrometry (B). Mean values ± standard 
deviation obtained from at least two independent mitochondrial isolations each analyzed in 
duplicate are shown in B. The asterisk in A indicates an unidentified lipid species. (C and D) PE 
and CL levels of mitochondria derived from cells overexpressing Gep1, Ups1 and Gep2. Phospho-
lipids were extracted from mitochondria and analyzed by TLC (C) and mass spectrometry (D). 
Mean values ± standard deviation obtained from at least two independent mitochondrial isolations 
each analyzed in duplicate are shown in D. 
A C 
B D 
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To further define functional links of PE and CL regulatory pathways, yeast strains, 
overexpressing Gep1, Gep2, or Ups1 were generated, mitochondria were isolated and 
subjected to lipid analysis employing TLC and mass spectrometry (Figure 19 C and D).  
A significantly reduced CL content accompanied by slightly increased PE levels was 
observed in mitochondria isolated from yeast cells overexpressing Gep1. The 
overexpression of Gep2 and Ups1 did not significantly affect PE and CL levels in 
mitochondria.  
 
In summary, these experiments indicate lipid-specific activities of Gep1 and Ups1 proteins 
for PE and CL and, at the same time, point to common steps in the regulation of both 
phospholipids within mitochondria. Both, the observed restoration of CL levels in ∆ups1 
cells upon deletion of GEP1 and the reduction of CL levels upon Gep1 overexpression 
suggests a competition between Gep1 and Ups1. 
 
2.2.1.2 CL and PE profiles of mitochondria lacking GEP genes 
As demonstrated by quantitative mass spectrometry, the proteins Gep1 and Ups1 play a 
crucial role in the regulation of mitochondrial PE and CL, respectively. Accordingly, other 
GEP genes may affect PE and CL levels in mitochondrial membranes as well. Therefore, 
mitochondria were isolated from yeast strains lacking Phb1 or GEP genes, and the levels 
of PE and CL were quantified by mass spectrometry (Figure 20). Mitochondrial PE and/or 
CL were affected in the majority of 23 examined strains. Only some strains showed 
normal PE and almost unaltered CL levels in mitochondria. The latter group included cells 
lacking assembly factors of the FO-subunit of the F1FO-ATP-synthase, like Atp10 and 
Atp23, that have been previously found to interact genetically with prohibitins (Osman et 
al., 2007), or Oxa1, for which a function during FO-assembly was recently described  
(Jia et al., 2007). Deletion of PSD1 or CRD1 resulted in the expected drastic reduction of 
the PE or CL content of mitochondrial membranes. Notably, increased PE levels were 
observed in cells showing a severely reduced CL content. This is in agreement with 
previous observations of an increase in mitochondrial PE in ∆crd1 cells, and suggested a 
coordinated regulation of both phospholipids (Zhong et al., 2004). Moreover, membranes 
isolated from Phb1-deficient mitochondria contained reduced amounts of CL and slightly 
increased PE levels. Strikingly, the loss of a large number of GEP genes, genetically 
interacting with prohibitins, led to strongly reduced levels of PE and/or CL. These included 
genes with functions for mitochondrial morphology and the assembly of β-barrel proteins 
(MDM10, MMM1, MDM31, MDM32, MDM34, and MDM35; (Merz et al., 2007; Bolender et 
al., 2008)), genes associated with the assembly of respiratory chain complexes (COX6, 
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YTA10, and YTA12), and several uncharacterized open reading frames (GEP3-6).  
Our findings indicate functions of these genes in the mitochondrial lipid metabolism and 
suggest a critical role of the PE and CL content of mitochondrial membranes for survival 
of prohibitin-deficient cells. 
 
Figure 20: CL and PE profiles of mitochondria lacking GEP genes. CL and PE levels were 
determined by mass spectrometry in mitochondria isolated from wt, ∆phb1 cells and cells lacking 
various GEP genes. Mean values of two mitochondrial lipid extracts are shown.  
2.2.1.3 A role for Gep4 in the biosynthesis of CL 
Mitochondria derived from the mutant ∆gep4 were further investigated for several 
reasons. First, ∆gep4 mitochondria showed, similar to ∆crd1 mitochondria, drastically 
reduced levels of CL (Figure 20 and Figure 21), indicating a role of Gep4 in the 
biosynthesis or regulation of mitochondrial CL. Second, a blast search revealed that Gep4 
and homologues in fungal and plant species are characterized by the presence of a 
hydrolase domain containing a conserved inverted DXDX(T/V) motif (Figure 22). 
Corresponding motifs were proposed to serve as intermediate phosphoryl-acceptors in 
various phosphotransferases (Collet et al., 1998). Based on these findings, it was 
hypothesized that Gep4 might be involved in the biosynthesis of CL by acting as a 
phosphatase dephoshorylating the lipid intermediate PGP. If this assumption is correct, 
PGP should accumulate in the absence of Gep4 in mitochondrial membranes. 
Consequentially, lipid extracts of ∆gep4 mitochondria were further investigated in order to 
identify and quantify the lipid intermediate PGP. 
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Figure 21: Quantification of phospholipids in wt, ∆gep4 and ∆crd1 mitochondria. Data represent 
mean values ± standard deviation of three (wt, ∆gep4) and two (∆crd1) independent mitochondrial 
isolations each analyzed in duplicate. **P<0.005, ***P<0.001. 
 
Figure 22: Alignment of proteins homologous to Gep4. The region containing the inverted 
phosphatase motif DXDX(V/T) is shown.  
2.2.1.3.1 PGP accumulates in ∆gep4 mitochondria 
It is known since decades that acidic extraction procedures strongly enhance the recovery 
of PIPs from biological membranes (see 2.1.3.1). PGP, with its two phosphate groups, is 
structurally related to the phosphoinositide PIP and can therefore be hardly recovered 
from membranes by conventional extraction procedures such as Folch (Folch et al., 1957) 
and Bligh and Dyer (Bligh and Dyer, 1959). In order to increase the recovery of PGP from 
mitochondrial membranes, an acidic lipid extraction was applied to wt, ∆crd1 and ∆gep4 
mitochondria and lipid extracts were analyzed by TLC and mass spectrometry (Figure 23). 
Strikingly, TLC analysis revealed the existence of a lipid class present in ∆gep4 but not in 
wt and ∆crd1 mitochondria (Figure 23 A). To confirm the identity of this lipid class, the 
band was recovered from the TLC plate and analyzed by mass spectrometry. Scanning 
for neutral losses of 269 Da (glyceroldiphosphate+NH3) unambiguously confirmed the 
band as PGP (Figure 23 B). The main species were found to be PGP 34:1, PGP 32:1, 
PGP 34:2 and PGP 32:2. PGP 36:2 and PGP 36:1 were detected to a lower extend.  
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Figure 23: Identification of PGP in ∆gep4 mitochondria by TLC and mass spectrometry. (A) Lipids 
were extracted from mitochondria by acidic extraction and separated by TLC. After isolating the 
band (indicated with PGP) from the TLC plate, PGP was identified by scanning for neutral losses of 
269 Da (B). PGP species are indicated by their fatty acid chain length and saturation state. The m/z 
values represent positively charged ammonium adducts of PGP.  
Mass spectrometric quantification of the identified PGP species revealed minute amounts 
of PGP in wt and ∆crd1 mitochondria with levels of ~0.02 mol% (Figure 24). Strikingly, in 
∆gep4 mitochondria, PGP accumulated ~50-fold to ~1.1 mol%, clearly indicating that in 
the absence of Gep4 dephosphorylation of PGP was inhibited. 
 
Figure 24: PGP accumulates in ∆gep4 mitochondria. Mass spectrometric quantification of PGP in 
wt, ∆gep4 and ∆crd1 mitochondria. Data represent mean values ± standard deviation of three  
(wt, ∆gep4) and two (∆crd1) independent mitochondrial isolations each analyzed in duplicate.  
A B 
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2.2.1.3.2 Gep4 dephosphorylates PGP 
In order to demonstrate that Gep4 
developed by Dr. Christof Osman
with a mutation in its phosphatase motif were expressed in 
affinity purification (data not shown) 
added to liposomes generated from lipid extracts of 
PG levels were monitored upon further incubation of the samples. As shown in
PGP was dephosphorylated and PG accumulated in the pre
PGP remained stable and PG was 
liposomes. Taken together, these results demonstrate
phosphatase activity. 
Figure 25: Gep4 dephosphorylates PGP 
liposomes generated from ∆
indicated time periods. Dephosphorylation of PGP (u
panel) were monitored. The asteri
in vitro 
dephosphorylates PGP an in vitro 
. N-terminally hexahistidine tagged Gep4 or Gep4
E. coli and purified by Ni
(Osman et al., 2010). Gep4 or Gep4
∆gep4 mitochondria, and PGP and 
sence of Gep4. In contrast, 
not detectable when Gep4D45N 
d that Gep4 exerts PGP 
in vitro. Purified Gep4 or Gep4D45N
gep4 mitochondrial lipid extracts and incubated at 25°C for 
pper panel) and formation of PG (bottom 
sk indicates an unidentified lipid species.  
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2.2.2 Ilimaquinone affects DAG level in Golgi membranes 
The marine sponge metabolite ilimaquinone (IQ) is known to induce reversible 
fragmentation of the Golgi complex and therefore used to analyze Golgi integrity and 
trafficking (Takizawa et al., 1993). Studies on the molecular mechanisms of IQ-induced 
Golgi vesiculation revealed that lipid modifying enzymes such as phospholipase D (PLD) 
and PA phosphatase (PAP) play essential roles in the fragmentation process (Sonoda et 
al., 2007). The lipid products of these enzymes, PA and DAG, have been intimately 
associated with vesicular transport processes (Riebeling et al., 2009; Siddhanta and 
Shields, 1998; Fernandez-Ulibarri et al., 2007). A detailed study on how DAG level are 
affected upon IQ-induced Golgi fragmentation has not been reported so far. We therefore 
aimed at a quantitative analysis of DAG in IQ-treated Golgi membranes that were kindly 
provided by our collaboration partner Dr. Josse van Galen (Research Group: Prof. Dr. 
Vivek Malhotra, Center for Genomic Regulation, Barcelona, Spain). 
 
Golgi membranes (~10-100 µg), treated either with DMSO (control) or IQ in DMSO, were 
extracted in the presence of the internal standard DAG 34:0 (17:0/17:0) and endogenous 
DAG species identified and quantified by MPIS as previously described (see chapter 
2.1.2.2 and 2.1.2.3). As shown in Figure 26 the DAG basal level in control Golgi 
membranes were quantified to ~9 pmol/µg protein (~0.8 mol% of phospholipids). Notably, 
IQ treatment of Golgi membranes resulted in significantly elevated DAG amounts of  
~14.5 pmol/µg protein (~1.3 mol% of phospholipids) indicating an increased production of 
DAG. Furthermore, slightly reduced PA levels in IQ-treated Golgi membranes compared 
to control Golgi membranes were also observed (data not shown). A reduction of PA is in 
agreement with a role of PA as DAG precursor, consequently, elevated DAG levels can 
be attributed to an increased PA phosphatase activity (Sonoda et al., 2007). The 
distribution of DAG molecular species revealed similar profiles in control and IQ-treated 
Golgi membranes (Figure 26 B), indicating that IQ is not affecting DAG level in a species 
specific manner.  
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Figure 26: Ilimaquinone treatment of Golgi membranes affects DAG level. (A) Absolute amounts of 
DAG level in control and IQ-treated Golgi membranes. (B) DAG species identified and quantified in 
Golgi membranes. Data represents mean values ± average deviation of four independent 
experiments. *p<0.05. 
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2.2.3 TCR stimulation affects PIP, PIP2 and DAG levels in human T cells 
Adaptive immunity requires the activation of T cells in order to accomplish the response 
towards a specific antigen. Activation of T cells is achieved by antigenic stimulation of the 
T cell receptor (TCR) (Rojo et al., 2008; Smith-Garvin et al., 2009). Activated T cells 
produce cytokines that are required for the modulation of other immune cells. The 
expression of many cytokines is triggered through the activation of transcription factors, 
which themselves are activated via intracellular signaling pathways induced by TCR 
ligation. These intracellular signaling cascades involve, among other factors, the activation 
of phospholipase Cγ1 (PLCγ1) which cleaves PI(4,5)P2 to generate the second mes-
sengers DAG and IP3 (Feske, 2007). DAG activates protein kinase Cθ (PKCθ), a critical 
player of the NF-κB pathway, and contributes to AP-1 activation via Ras/ERK. IP3 on the 
other hand triggers Ca2+-release from the ER leading to calcium entry and NFAT 
activation. Activation of all three transcription factors (AP-1, NF-κB and NFAT) is needed 
for the expression of certain cytokines such as the Th1-type cytokines IL-2 and IFNγ. 
 
Our collaboration partner Angelika Schmidt (Research Group: Prof. Dr. Peter H. Krammer, 
DKFZ, Heidelberg) is particularly interested in the molecular mechanisms of how 
regulatory T cells (Tregs) suppress cytokine transcription of conventional T cells (Tcons). 
In vitro experiments, employing Tcon and Treg coculture, revealed fast kinetics of Tcon 
suppression in the presence of Tregs (Oberle et al., 2007). The exact mechanism of sup-
pression, however, is still unknown. In order to address the question whether Tregs affect 
TCR proximal signaling events in Tcons, particularly at the level of lipids, we aimed for a 
quantitative analysis of PIP, PIP2 and DAG levels in Tcons that were suppressed by 
Tregs. 
 
Initially, to define stimulation conditions that give rise to significant changes in profiles of 
signaling lipids, PIP, PIP2 and DAG levels were quantified in stimulated control Tcons (not 
cocultured with Tregs). Tcons were TCR-stimulated for 0.5 min, 1 min, 3 min and 5 min by 
anti-CD3 antibodies, costimulation was achieved with anti-CD28 antibodies, and cross-
linking antibodies were added in addition to enhance stimulation. ~5-10 x 106 cells were 
taken for each experiment and subjected to a two-step lipid extraction (see chapter 
2.1.3.1). DAG quantification was performed in neutral extracts, whereas PIP and PIP2 
level were quantified in acidic extracts. The sole PIP2 species that could be detected by 
scanning for neutral losses of 437 Da was PIP2 38:4 (data not shown). Consequently, PIP 
38:4 and DAG 38:4 were analyzed in order to monitor PIP2-related effects on DAG and 
PIP. As shown in Figure 27, TCR stimulation induced visible changes in the profiles of 
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PIP, PIP2 and DAG in Tcons. PIP 38:4 was constantly increased at any stimulation time 
accompanied by a slight but stable reduction of PIP2 38:4. Noticeably, DAG 38:4, which 
remained relatively unaffected after 0.5 min and 1 min of stimulation, was massively 
produced after longer stimulation times of 3 min and 5 min indicated by >2-fold elevated 
levels compared to unstimulated cells of the same donor. 
 
Figure 27: TCR stimulation affects level of signaling lipids in primary human T cells (Tcons). Tcons 
were left unstimulated or stimulated with crosslinked anti-CD3/CD28 antibodies. DAG and PIPs 
were extracted by a two-step extraction. Quantification of PIP and PIP2 was performed in acidic 
extracts. Quantification of DAG was performed in neutral extracts. PIP, PIP2 and DAG amounts 
were normalized to PC (quantified in neutral extracts). Unstimulated cells were set to 1 for each 
individual donor. Data represent mean values ± standard deviation of the indicated number of 
individual donors. *p<0.05, **p<0.01. 
Taken together, the mass spectrometric quantification of PIP, PIP2 and DAG showed that 
TCR stimulation induces measurable changes in the levels of Tcon signaling lipids under 
the applied conditions. Whereas PIP and PIP2 levels were only slightly affected, the 
amount of DAG increased significantly after longer stimulation times (3 min and 5 min). 
Therefore, stimulation times of 3 min and 5 min were chosen for further experiments in 
order to analyze the impact of Tregs on the level of the signaling lipids PIP, PIP2 and DAG 
in Tcons (data not shown). 
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2.3  Quantitative lipid analysis of Golgi membranes and COPI vesicles 
COPI vesicles are Golgi-derived transport carriers that operate in the early secretory path-
way (Beck et al., 2009). COPI vesicles have been implicated in the retrograde transport of 
proteins from the Golgi to the ER (Nickel and Wieland, 1998) and are thought to function 
in bidirectional transport within the Golgi complex (Orci et al., 2000; Orci et al., 1997). 
Whereas protein transport has been characterized in great detail, less is known about the 
role of COPI vesicles in transport and sorting of lipids. Brügger et al employed nano-ESI-
MS/MS for a quantitative lipid analysis of Golgi membranes and COPI vesicles and found 
that SM and cholesterol are segregated during the formation of COPI-coated vesicles 
(Brugger et al., 2000). In order to gain deeper insight into vesicle-mediated lipid sorting an 
extended lipidome analysis of Golgi membranes and COPI vesicles was performed. 
 
2.3.1 Characterization of subcellular fractions and generation of COPI 
 vesicles 
Rat liver Golgi membranes were prepared as described (Brugger et al., 2000) with the 
exception that Golgi fractions were not subjected to a second gradient for further 
purification. Relative enrichment of Golgi membranes and the degree of cross-
contamination with other organelles was determined by measuring the distribution of 
marker enzymes for Golgi (galactosyltransferase), ER (NADH-cytochrome c reductase), 
plasma membrane (alkaline phosphodiesterase) and lysosomes/late endosomes (β-N-
acetylglucosaminidase). Enrichment of marker enzymes is expressed as the ratio of 
specific enzyme activity (units/mg protein). Golgi fractions taken for vesicle preparations 
were characterized by 18-fold enrichment of a Golgi marker, 3.4-fold enrichment of a 
plasma membrane marker, 0.5-fold enrichment of a lysosome/late endosome marker and 
1.3 enrichment of an ER marker. 
 
COPI vesicles were generated in vitro in the presence of rat liver cytosol (RLC) and 
GTPγS. COPI vesicle fractions were analyzed for the presence of mannosidase II (ManII), 
delta-COP (δCOP), the p24 family member p27 and ADP-ribosylation factor 1 (Arf1) 
(Figure 28). Typically, ~0.8-1.2% of Golgi donor membranes were converted into COPI 
vesicles (assessed by the PC content of Golgi membranes and COPI vesicles). 
Additionally, as a blank control for quantitative lipid analysis, COPI vesicle fractions, 
obtained from the incubation of donor Golgi membranes in the presence of RLC but in the 
absence of GTPγS, were prepared. This control was included to compensate for lipid 
contaminations derived from RLC. RLC was found to contain significant amounts of lipid 
impurities (~3.5 nmol PC/mg protein) which had the tendency to migrate into COPI 
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Figure 29: Lipid quantification of Golgi membranes and COPI vesicles. (A) All analyzed lipid 
classes are displayed. (B) Low abundant lipid classes (<10 mol %) are displayed at a different 
scale. Data represents mean values ± average deviation of three and two (LPE) independent 
experiments. 
2.3.3 Distribution of lipid species in Golgi membranes and COPI vesicles  
Besides changes in the absolute amounts of lipid classes we next asked whether single 
lipid species were selectively enriched or reduced in COPI vesicles compared to the donor 
Golgi membrane. The profiles of the molecular species of PC revealed no drastic changes 
between Golgi and COPI vesicles at a first glance, however, a more careful inspection of 
the pattern showed very little but apparent differences (Figure 30). The low abundant 
species PC 32:0 was found to be ~2.4-fold reduced in COPI vesicles accompanied by a 
very slight reduction of PC 34:2, PC 34:1, PC 36:2 and PC 36:1. In contrast, species with 
a higher degree of unsaturation such as PC 36:4, PC 38:6, PC 38:5 and PC 38:4 were 
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slightly enriched in COPI vesicles compared to the donor Golgi membrane. The PS 
species distribution seemed to follow in part the same tendency, indicated by slightly 
reduced levels of PS 36:1 and PS 36:2 together with increased levels of PS 38:4 and  
PS 38:5 in COPI vesicles (Figure 34). 
 
For the phospholipids PE and PI no differences in the species pattern between Golgi and 
COPI vesicles were observed (Figure 31 and Figure 33). However, the ether lipid species 
pl-PE 16:0p/20:4 was found to be enriched in COPI vesicles accompanied by a reduction 
of pl-PE 16:0p/22:4 and pl-PE 18:0p/20:4, respectively (Figure 32). The lysolipid species 
LPC 16:0 and LPC 18:0 were slightly reduced in COPI vesicles, in contrast LPC 22:4 and 
LPC 22:0 were found to be strongly enriched in vesicles (Figure 35). The LPE species 
analysis revealed that saturated LPE 18:0 was enriched in COPI vesicles whereas other 
LPE species remained largely unaffected (Figure 36). The sphingolipid species SM 24:2 
was enriched in COPI vesicles, accompanied by a depletion of SM 26:0 (Figure 37). 
Saturated ceramide 22:0 was depleted in COPI vesicles whereas ceramide 24:0 was 
slightly enriched in the vesicles (Figure 38). 
 
Taken together, these results showed for the first time a comprehensive lipidome analysis 
of Golgi membranes and COPI vesicles derived thereof. We found that SM and 
cholesterol are segregated during the formation of COPI vesicles which is consistent to 
previous observations (Brugger et al., 2000). Moreover, the sphingolipid ceramide, the 
ether lipid pl-PE, the aminophospholipid PS and the lysolipids LPC and LPE were all 
found to be reduced in COPI vesicles indicating that these lipid classes are segregated 
together with SM and cholesterol during the formation of COPI vesicles.  
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Figure 30: PC species distribution in Golgi membranes and COPI vesicles. Data represents mean 
values ± average deviation of three independent experiments. 
 
Figure 31: PE species distribution in Golgi membranes and COPI vesicles. Data represents mean 
values ± average deviation of three independent experiments. 
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Figure 32: pl-PE species distribution in Golgi membranes and COPI vesicles. Data represents 
mean values ± average deviation of three independent experiments. 
 
Figure 33: PI species distribution in Golgi membranes and COPI vesicles. Data represents mean 
values ± average deviation of three independent experiments. 
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Figure 34: PS species distribution in Golgi membranes and COPI vesicles. Data represents mean 
values ± average deviation of three independent experiments. 
 
Figure 35: LPC species distribution in Golgi membranes and COPI vesicles. Data represents mean 
values ± average deviation of three independent experiments. 
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Figure 36: LPE species distribution in Golgi membranes and COPI vesicles. Data represents mean 
values ± average deviation of two independent experiments. 
 
Figure 37: SM species distribution in Golgi membranes and COPI vesicles. Data represents mean 
values ± average deviation of three independent experiments. Note: the SM species data is derived 
from SM analysis after mild alkaline hydrolysis of PC species that appear in the same mass 
spectrometric scan (PIS m/z 184). Since SM 16:0 was hardly detectable after alkaline hydrolysis, 
the data for SM 16:0 was taken from the PIS m/z 184 scan before alkaline hydrolysis.  
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Figure 38: Ceramide species distribution in Golgi membranes and COPI vesicles. Data represents 
mean values ± average deviation of three independent experiments. 
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3 Discussion 
Within the course of this thesis, nano-ESI-MS/MS for automated lipid analysis was set up 
(Ejsing et al., 2006) and employed to establish methods for the quantification of CL, DAG, 
PIP and PIP2. The methods were applied in order to address scientific questions related to 
mitochondria, the Golgi complex and primary human T cells. Additionally, a quantitative 
lipidome analysis of Golgi membranes and COPI vesicles was performed in order to gain 
insight into COPI vesicle-mediated lipid sorting. 
 
3.1 Method development 
3.1.1 Quantification of CL 
To study the impact of GEP genes on mitochondrial lipids, a method for the identification 
and quantification of CL molecular species was established. To this end, two CL species, 
CL 56:0 and CL 72:4 were characterized with respect to their mass spectrometric 
behavior similar as described (Han et al., 2006). The suitability of CL 56:0 as internal 
standard for CL quantification was shown in other studies as well (Valianpour et al., 2002; 
Valianpour et al., 2005; Sparagna et al., 2005). CL has previously been analyzed as singly 
(Sparagna et al., 2005) or doubly charged ion (Valianpour et al., 2002; Han et al., 2006; 
Garrett et al., 2007). When infused in solvents consisting of chloroform/methanol (Han et 
al., 2006) or methanol (this study), CL favors the doubly charged ionization state rather 
than the singly charged state. Interestingly, Sparagna et al found that the charge state of 
CL is also affected by the instrument design of the mass spectrometer (triple quadrupole 
or quadrupole time-of-flight), irrespective of the solvent system used for the infusion 
(Sparagna et al., 2005). When analyzing CLs on a quadrupole time-of-flight mass 
spectrometer (nano-ESI), we found that the distribution of singly and doubly charged CL 
ions can be influenced by changing the composition of the solvent system. The addition of 
ammonium acetate and piperidine supported the singly charged state of CL. Monitoring on 
singly charged CLs was assumed to be advantageous for the analysis of crude lipid 
mixtures in order to avoid interference with glycerophospholipids such as PE, PA and PG 
that appear in the same mass range. Furthermore, a titration analysis revealed that the 
quantification limit of singly charged CLs in the product ion mode (~1 nM) was 10-fold 
lower than any other reported quantification limit for CL analysis (Han et al., 2006; 
Valianpour et al., 2002). Besides being very sensitive the product ion mode features more 
advantages. First, the system is less susceptible to detector saturation, thus increasing 
the dynamic range towards higher sample concentrations. Second, fragmentation of lipid 
precursors reveals additional information about the fatty acid composition of the parent  
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CL molecules, which is in particular important for the analysis of CL fatty acid remodeling 
(Xu et al., 2003).  
 
A titration analysis of CL 72:4 in lipid extracts of ∆crd1 mitochondria demonstrated that 
product ion analysis of singly charged ions facilitates the quantification of CLs in the 
presence of crude lipid mixtures. In summary, 28 CL species were identified in yeast 
mitochondria, thus representing a comprehensive spectrum of CL species that could be 
identified by the established method. The basal level of CL in wt mitochondria was 
quantified to ~15 mol% of phospholipids which is in accordance with previous findings 
(Daum and Vance, 1997).  
 
3.1.2 Quantification of DAG 
The mass spectrometric analysis of DAG 34:1 confirmed that DAG forms positively 
charged ammonium adducts that, upon collision-induced dissociation, display lipid class 
specific fragments derived from neutral losses of H2O + NH3 (35 Da) and fatty acid 
fragments RCOOH + NH3 (Murphy et al., 2007). The latter neutral loss fragments result in 
characteristic MAG-H2O ions, that, due to a better dissociation efficiency, were chosen to 
set up DAG-specific MPIS as described (Stahlman et al., 2009). For quantification, the 
internal standard DAG 34:0 (17:0/17:0) was used (Stahlman et al., 2009; Ejsing et al., 
2009). 
 
Although scanning for neutral losses of 35 Da allowed the identification of DAGs (data not 
shown), not all molecular species were detected with the same sensitivity. This was in 
particular the case for DAG 38:4 which showed a drastically reduced NL 35 fragmentation 
efficiency compared to all other examined DAG species. Most likely, this effect can be 
attributed to the polyunsaturated fatty acid 20:4 that might influence the fragmentation 
behavior of polyunsaturated species. Further experiments are required to reveal additional 
information about the mass spectrometric dissociation behavior of DAG 38:4. Several 
scenarios should be considered: (i) DAG fragmentation is generally affected by the 
saturation state of the fatty acids. The inspection of species containing fatty acids with 
different degrees of unsaturation (e.g. DAG 36:3 and DAG 40:6) will shed light on this 
issue. (ii) Although DAG species used in this study were supposed to be sn-1,2 positional 
isomers, DAGs tend to isomerize to more stable sn-1,3 isomers by transposition of the 
fatty acid group during storage and sample processing. Thus, it is possible that DAG 38:4 
is more susceptible to isomerization and that this, in consequence, affects the 
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fragmentation behavior. The isomerization state of DAG species should therefore be care-
fully determined in future studies (Rosati et al., 2007).  
 
To demonstrate that endogenous DAG can be identified and quantified, the established 
MPIS method was applied to Golgi membranes. The analysis of several Golgi fractions 
revealed quite variable DAG amounts between 5-100 pmol/µg protein. These amounts are 
in overall agreement with previously reported data of ~32-70 pmol DAG/µg protein in rat 
liver Golgi membranes (Stremmel and Debuch, 1979). Similar results were reported for 
yeast-derived trans-Golgi network (TGN) fractions where DAG was quantified to  
~8.5 mol% of lipids which reflects ~90 pmol/µg protein (Klemm et al., 2009). However, our 
observations together with the reported data are still discrepant to very low DAG amounts 
that were reported for Golgi fractions derived from HeLa cells (0.55 pmol/µg) (Fernandez-
Ulibarri et al., 2007). Further studies are required in order to solve these discrepancies 
since we have currently no explanation for the quantitative differences. 
 
Given the fact that purified Golgi fractions contain large amount of neutral lipids 
(Zambrano et al., 1975; Keenan and Morre, 1970; Yunghans et al., 1970; Stremmel and 
Debuch, 1979) it was not surprising to detect high DAG levels in Golgi membranes. 
Neutral lipids in Golgi fractions are derived from lipid droplets and lipoprotein particles that 
are secreted from the Golgi (Hess et al., 1979). Such particles contain huge amounts of 
TAG that could be degraded to DAG by lipases (Smirnova et al., 2006) during the Golgi 
preparation process. Thus, a possible explanation for the variability in DAG levels could 
be due to different amounts of lipid droplets or lipoprotein particles that co-migrate into the 
Golgi fraction. 
 
3.1.3 Quantification of PIP and PIP2 
To specifically enrich PIPs from HeLa cells, a two-step extraction procedure (Gray et al., 
2003) was performed and the extraction behavior of PIPs was investigated by auto-
radiography. The finding that PIP and PIP2 were recovered with 58% and with 79% in 
acidic extracts of HeLa cells is not consistent with observations by Gray et al who reported 
recoveries of 74% PIP and 94% PIP2 in acidic extracts of astrocytoma cells (Gray et al., 
2003). These discrepancies in the extraction behavior of PIP and PIP2 are most likely due 
to the different cell types used for the extraction analysis. Astrocytoma cells contain large 
amounts of cerebrosides, sulfatides and plasmalogens (Norton et al., 1975) whereas 
HeLa cells do not. Such differences in the membrane lipid composition might explain a 
greater loss of PIPs during the neutral extraction in HeLa cells and consequently lower 
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yields in the acidic extract. Further studies are required in order to clarify the extraction 
behavior of endogenous PIPs from different cell types. 
 
All available mass spectrometric methods for the measurement of PIPs rely on the 
analysis of PIPs in negative ionization mode (Wenk et al., 2003; Milne et al., 2005; Pettitt 
et al., 2006) what should be beneficial because of the negatively charged phosphate 
groups. However, we found that negatively charged PIPs showed a variable ionization 
behavior on our nano-ESI-MS/MS system (data not shown). Consequently, it was not 
possible to create conditions that resulted in a constant stream of either singly or doubly 
charged PIPs. Negatively charged PIPs were rather fluctuating between the singly and the 
doubly charged state and thus did not allow robust analysis (data not shown). In contrast, 
positively charged ammonium adducts (presented in this study) resulted in a stable 
ionization behavior of PIP and PIP2 and thus allowed the identification and quantification 
of PIPs in positive ionization mode. Collision-induced fragmentation of PI(4)P 37:4 and 
PI(4,5)P2 37:4 ammonium adducts revealed lipid class specific neutral losses of  
357 Da (PIP) and 437 Da (PIP2), respectively. The identification and quantification of PIP 
and PIP2 by neutral loss scanning was confirmed by profiling of complex PI(4)P brain and 
PI(4,5)P2 brain mixtures. As proof of principle, it was demonstrated that a selective two-
step extraction allowed the mass spectrometric analysis of PIP and PIP2 in HeLa cells. 
The quantified amounts of 0.34 mol% PIP and 0.49 mol% PIP2 were in agreement with 
previous reports (Mallo et al., 2008).  
 
Although PIP3 was detected in HeLa cells (data not shown), attempts to quantify PIP3 in a 
robust manner failed so far. PIP3 is an extremely low abundant lipid class accounting to 
<0.0002 mol% of phospholipids in HeLa cells (Mallo et al., 2008). Besides the extreme 
low abundance, another difficulty of PIP3 analysis results from a reduced ionization 
efficiency that correlates with the number of phosphate groups (Wenk et al., 2003; Pettitt 
et al., 2006). Therefore, to compensate for low abundances and for reduced ionization 
efficiencies of PIP3, more starting material (>10 x 106 cells) will be needed for future 
experiments.  
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3.2 Method application 
3.2.1 Genetic interactors of prohibitins regulate mitochondrial PE and CL 
Although almost all enzymes of lipid biosynthetic pathways have been identified in yeast 
mitochondria, little is known about regulatory mechanisms that control and maintain 
mitochondrial lipid composition. During this study, we focused on PE and CL, two 
phospholipids that are important for mitochondrial function and membrane biogenesis. PE 
and CL can substitute for each other which is supported by the finding that PE and CL 
biosynthetic pathways are synthetic lethal in yeast (Gohil et al., 2005). Compensatory 
effects of PE and CL can be attributed to the ability of both lipids to form hexagonal phase 
(non-bilayer) structures in membranes (Cullis and de Kruijff, 1978; Vasilenko et al., 1982; 
Dowhan, 1997). Non-bilayer lipids are discussed to be involved in the lateral stabilization 
and movement of proteins (Cullis and de Kruijff, 1979; Schlame et al., 2000; van den 
Brink-van der Laan et al., 2004; Dowhan, 1997; Pfeiffer et al., 2003) and membrane fusion 
events (Verkleij et al., 1984). Contact sites between the inner and outer mitochondrial 
membrane are enriched in CL and PE (Daum and Vance, 1997; Ardail et al., 1990), thus 
supporting the idea that both lipids are involved in the transport of proteins and lipids 
through contact sites. Moreover, PE and CL cluster have been identified in bacteria where 
they may function as membrane organizers required for cell division and sporulation 
(Nishibori et al., 2005; Matsumoto et al., 2006; Kawai et al., 2004). 
 
Mass spectrometric quantification of CL and PE in mitochondria derived from yeast 
deletion mutants whose genes were identified in a screen to genetically interact with 
prohibitins (GEP genes) revealed regulators that are required for normal PE (Psd1, 
Mdm35 and Gep1), normal CL (Ups1, Mdm34, Gep4, Mdm32 and Crd1) or normal PE 
and CL levels (Mmm1, Mdm31, Yta10, Yta12, Cox6, Gep3, Gep5 and Gep6) (Figure 39) 
(Osman et al., 2009) and reviewed in (Gohil and Greenberg, 2009).  
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Figure 39: Genetic interactors of prohibitins (GEP genes) regulate the levels of PE and CL. GEP 
genes consist of three classes that are involved in the regulation of PE, CL or both PE and CL in 
yeast mitochondria. Taken from Gohil and Greenberg 2009.  
Within the set of identified GEP genes, two proteins, Gep1 and Ups1 were analyzed in 
detail to study their function in regulating mitochondrial PE and CL. The data revealed that 
the accumulation of PE depends on Gep1, whereas Ups1 controls CL level in mito-
chondria. Strikingly, CL was found to be reduced upon overexpression of Gep1 and PE 
was slightly reduced upon overexpression of Ups1 (Figure 19). This suggests a 
competition between Gep1 and Ups1 and supports the idea that mitochondrial PE and CL 
levels are regulated coordinately by Gep1 and Ups1. Consistently, deletion of GEP1 in 
∆ups1 cells restored mitochondrial CL level (Figure 19).  
 
Recent studies showed that Ups1 and Gep1 (also termed Ups2) regulate mitochondrial 
CL antagonistically and furthermore, a critical connection between the regulation of CL by 
Ups1 and Gep1 and the assembly state of the TIM23 translocase was discovered 
(Tamura et al., 2009). Other studies demonstrated that the ability of Ups1 and Gep1 to 
regulate CL and PE depends on Mdm35, which was found to protect Ups1 and Gep1 
against proteolysis by the protease Yme1 and the peptidase Atp23 (Potting et al., 2010).  
 
Although a plethora of data indicates a coordinated regulation of PE and CL level by Gep1 
and Ups1, the underlying molecular mechanisms remain to be determined. The 
observation that the absence of both, Gep1 and Ups1 (∆gep1∆ups1) only slightly affect 
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mitochondrial PE and CL levels makes it unlikely that both proteins are enzymes of bio-
synthetic PE and CL pathways. This assumption was confirmed for Gep1, as it was shown 
to be dispensable for PE synthesis but rather controls the stability of PE (data not shown) 
(Osman et al., 2009). Therefore, Gep1 most likely regulates the degradation of PE by 
inhibiting a lipase or, alternatively, Gep1 plays a role in export of PE from mitochondria. 
The scenario that Gep1 regulates PE export is consistent with the fact that significant 
amount of cellular PC (produced in MAMs and the ER) is derived from mitochondrial PE 
(Daum and Vance, 1997). Interestingly, ∆gep1 mitochondria contained slightly elevated 
levels of PC (Figure 19 A), which could be the result of MAM/ER-produced PC that is re-
imported to mitochondria. The role of Ups1 in maintaining physiological CL level is 
currently less clear, and further experiments are required to examine whether Ups1 
affects CL biosynthesis or degradation. Two possible mechanisms of Ups1-dependent  
CL regulation can be envisaged: (i) Ups1 controls enzymes of the CL biosynthetic 
pathway, e.g. by the inhibition of Crd1 or Gep4, or (ii) Ups1 protects mitochondrial CL 
from degradation by the inhibition of a CL-specific lipase. 
 
Taken together, the mass spectrometric quantification of CL and PE in GEP mutants 
revealed a critical connection between prohibitins, GEP genes and the regulation of 
mitochondrial lipid levels. Consequently, reduced levels of mitochondrial PE and CL also 
affect mitochondrial structure by affecting the lipid composition as well as protein stability 
in membranes. Ring-like prohibitin complexes may therefore function as membrane 
organizers that influence the distribution of PE and CL in mitochondrial membranes. The 
synthetic lethality of Psd1 and Crd1 with prohibitins supports the idea that prohibitins are 
required to maintain inner membrane integrity when mitochondrial PE and CL levels are 
decreased. PE and CL clusters have been observed in bacterial membranes (Matsumoto 
et al., 2006). It is tempting to speculate that such domains also exist in mitochondria. Such 
clusters could be involved in generating and maintaining contact sites between inner and 
outer mitochondrial membranes that are enriched in CL and PE (Daum and Vance, 1997; 
Ardail et al., 1990). In case of low PE and CL levels, prohibitins might compensate for the 
loss of these lipids by maintaining contact sites and consequently mitochondrial integrity 
and function. This scenario is in agreement with a putative scaffolding function of 
prohibitins (Merkwirth and Langer, 2009b; Langhorst et al., 2005). 
 
Although almost all enzymes of CL biosynthesis are known in yeast, there are still players 
that need to be identified. The unknown gene GEP4 was identified as a GEP gene that is 
required for normal CL levels in mitochondria (Figure 20 and Figure 21). The finding that 
the encoded protein Gep4 contains a phosphoryl-acceptor motif suggested that Gep4 
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might be involved in the biosynthesis of mitochondrial CL by acting as a PGP 
phosphatase. Mass spectrometric identification and quantification revealed a ~50-fold 
accumulation of PGP in ∆gep4 mitochondria. This observation was an important result, 
stimulating further experiments that lead to the identification of Gep4 as a phosphatase 
required for CL synthesis (Osman et al., 2010). 
 
3.2.2 Ilimaquinone affects DAG level in Golgi membranes 
Ilimaquinone (IQ) is a marine sponge metabolite that induces fragmentation of the Golgi 
complex (Takizawa et al., 1993) and is therefore used to analyze Golgi integrity and 
trafficking (Jamora et al., 1997; Acharya et al., 1995; Taylor et al., 1994; Veit et al., 1993). 
There is evidence that IQ´s ability to vesiculate the Golgi complex can be attributed to an 
interaction of IQ with methylation enzymes (Casaubon and Snapper, 2001; Radeke et al., 
1999). Other studies demonstrated that Golgi-associated phospholipase D (PLD) 
(Ktistakis et al., 1996; Ktistakis et al., 1995) is required for IQ-induced Golgi fragmentation 
(Sonoda et al., 2007). The authors concluded from their results that activation of PLD 
generates PA that is further converted by PA phosphatase (PAP) to DAG which binds and 
activates protein kinase D (PKD) followed by Golgi vesiculation. Although there is 
compelling evidence that IQ stimulates the production of DAG in Golgi membranes, this 
has not yet been confirmed by quantitative lipid analysis.  
 
Quantitative lipid analysis of Golgi membranes showed that DAG level indeed elevated 
upon IQ treatment (Figure 26). Accordingly, this finding is in agreement with the scenario 
that activation of PLD and PAP results in elevated DAG levels in Golgi membranes. In 
future studies it will be interesting to see whether IQ additionally affects other lipids. If so, 
the main question will be, whether IQ alters Golgi lipid levels by activating other lipid 
modifying enzymes or if IQ mediates Golgi fragmentation through a direct interaction with 
Golgi membranes. A direct interaction between Golgi membranes and the Golgi- 
vesiculating agent norrisolide has recently been observed (Guizzunti et al., 2010). 
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3.2.3 TCR stimulation affects PIP, PIP2 and DAG levels in human T cells 
Identification and quantification of PIP, PIP2 and DAG under different cellular conditions 
was demonstrated by the analysis of TCR-stimulated conventional human T cells (Tcons). 
The aim of this experiment was to determine conditions that give rise to significant 
changes in the level of the signaling lipids PIP, PIP2 and DAG in order to address the 
future question whether regulatory T cells (Tregs) affect TCR proximal signaling events in 
Tcons with regard to the lipid composition. 
 
It was found that TCR stimulation of Tcons by adding anti-CD3/CD28 antibodies resulted 
in significantly increased DAG levels after 3 min and 5 min (Figure 27) which was 
consistent with kinetics of PLCγ1 and PKCθ activation (observation by Angelika Schmidt, 
Research Group: Prof. Dr. Peter H. Krammer, DKFZ, Heidelberg). Furthermore, PIP2 
levels were constantly and significantly reduced upon TCR stimulation (Figure 27) which 
was consistent to activated PLCγ1 (observation by Angelika Schmidt). Noticeably, the 
accumulation of DAG was only concomitant to a reduction of PIP2 after 1 min stimulation 
time. In contrast, stimulation for 3 min and 5 min tremendously increased DAG levels, 
whereas PIP2 did not drop to the same extend. Two possibilities can be envisaged to 
explain this effect. First, the re-synthesis rate of PIP2 is especially increased after 3 min 
and 5 min stimulation. This scenario is supported by elevated levels of PIP, the precursor 
of PIP2 biosynthesis. Furthermore, the synthesis rate of PIPs is known to be massively 
increased upon TCR stimulation (Zaru et al., 2001). Second, DAG can be generated from 
other lipid precursors as well. Although it is widely accepted that TCR stimulation triggers 
PLCγ1 that cleaves plasma membrane anchored PI(4,5)P2, there is evidence that 
activation of Ras/MAPK pathways by DAG can also occur at the Golgi complex (Mor and 
Philips, 2006). Thus other lipid precursors might contribute to the production of DAG, such 
as PC that can be converted to DAG by the action of PLD and PA phosphatase, enzymes 
that have previously been linked to TCR signaling (Mor et al., 2007).  
 
To clarify the source of DAG in the Tcon subset used in this work, the analysis of PIP2 
derived inositol-phosphate intermediates will be required in future studies. Furthermore, it 
will be interesting to see whether Treg-induced suppression of Tcons is achieved by 
affecting proximal signaling events that include PIP, PIP2 and especially DAG levels, or 
whether Tregs regulate suppression of Tcons by affecting downstream signaling events. 
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3.3 Quantitative lipid analysis of Golgi membranes and COPI vesicles 
3.3.1 Characterization of subcellular fractions and generation of COPI 
 vesicles 
According to enzymatic assays, the Golgi fraction was 18-fold enriched in a Golgi marker 
which was significantly less Golgi enrichment compared to previous observations (90-fold 
enrichment) (Brugger et al., 2000). The contributions of plasma membrane and endo-
plasmatic reticulum to the Golgi fraction was comparable to previous reports, however, 
lysosome/late endosome-derived impurities were found to be lower than previously 
observed (Brugger et al., 2000). The discrepant Golgi enrichment factors can most likely 
be attributed to differences in the Golgi purification protocols. Whereas Brügger et al 
subjected Golgi membranes to a two-step purification (Brugger et al., 2000), a second 
purification step was omitted in this study. Furthermore, it is known that the presence of 
protease inhibitors during Golgi purification (this study) can lower the apparent purification 
factors (Hui et al., 1998). Another explanation is that the Golgi fraction used for this study 
contains only low amounts of TGN-cisternae which would explain a reduced activity of 
TGN-located galactosyltransferase.  
 
For the upcoming discussion several things should be kept in mind when comparing the 
data presented here with previous observations (Brugger et al., 2000). First, Golgi 
fractions used in the present study and in the previous study (Brugger et al., 2000) are not 
comparable in terms of purity. Thus, any observed differences in lipid class and lipid 
species distribution between donor Golgi membranes and COPI vesicles can be the result 
of slightly different lipid compositions of the donor Golgi membranes used. Second, COPI 
vesicles were prepared in the presence of rat liver cytosol in this study, whereas 
previously bovine brain cytosol was used for the generation of COPI vesicles (Brugger et 
al., 2000). Thus, any observed effect can likely be attributed to different cytosolic com-
positions that might result in the formation of different types of COPI vesicles. 
 
3.3.2 Quantitative lipid analysis of subcellular fractions 
The quantitative lipid data of Golgi membranes is in overall agreement with previous data 
(Yunghans et al., 1970; Keenan and Morre, 1970; Zambrano et al., 1975; Fleischer et al., 
1974). Quantitative lipid analysis of COPI vesicles revealed that SM was reduced  
~2.5-fold from ~5 mol% in the Golgi to ~2 mol% in COPI vesicles (Figure 29). Cholesterol 
was reduced ~2-fold from ~10 mol% in the Golgi to ~5 mol% in COPI vesicles (Figure 29). 
The depletion factors are in line with earlier findings that revealed a ~3.3-fold and  
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~1.6-fold reduction of SM and cholesterol, respectively (Brugger et al., 2000). COPI 
vesicles were also found to contain low levels of pl-PE, PS, LPC, LPE and ceramide 
compared to the donor Golgi. Two lipid classes, PC and PI, were specifically enriched in 
COPI vesicles whereas PE was not affected during vesicle formation. Consequentially, 
the lipid composition of COPI vesicles reflects an “ER-like” pattern, characterized by low 
amounts of SM, cholesterol and PS and high amounts of PC and PI (van Meer et al., 
2008; van Meer, 1998). 
 
3.3.3 Distribution of lipid species in Golgi membranes and COPI vesicles 
The profiles of PC molecular species revealed no drastic changes between Golgi 
membranes and COPI vesicles at a first glance. However, a more careful inspection of the 
profiles revealed very little but apparent changes that were contradictory to previous 
observations that showed an enrichment of PC 34:1 and PC 40:6 in COPI vesicles 
accompanied by a reduction of PC 40:7 (Brugger et al., 2000). In contrast, this study 
revealed that saturated PC 32:0 was significantly reduced in COPI vesicles, indicating that 
PC 32:0 is segregated together with SM and cholesterol in liquid-ordered phases during 
COPI vesicle budding. Interestingly, detergent resistant membranes (DRMs) contain, 
besides high amounts of SM and cholesterol, elevated levels of PC 32:0 (Brugger et al., 
2004; Hein et al., 2008). Furthermore, saturated PC species show high affinity to SM and 
cholesterol rich domains at the PM (Harder and Sangani, 2009). The data suggested that 
other PC species are also sorted, but to a lower extent than PC 32:0. In general, PC 
species with a higher degree of saturation (PC 34:1, PC 34:2, PC 36:1 and PC 36:2) 
seemed to be slightly retained in the Golgi. In contrast, the small enrichment of 
unsaturated species (PC 36:4, PC 38:6, PC 38:5 and PC 38:4) in COPI vesicles was 
consistent with the enrichment of polyunsaturated PI 38:4 in COPI vesicles. The small, but 
obvious changes in the PC species profiles of COPI vesicles compared to the donor Golgi 
membrane supports the idea that COPI vesicles are involved in a fine-tuned sorting 
process of PC species along the secretory pathway. 
 
On the level of SM species, we could not confirm an enrichment of SM 18:0 and a 
reduction of SM 24:0 and SM 24:1 in COPI vesicles as observed previously (Brugger et 
al., 2000). However, it was found that SM 24:2 is enriched in COPI vesicles accompanied 
by a reduction of SM 26:0 (Figure 37). Furthermore, changes in the species profiles of 
other lipid classes such as pl-PE, LPC, LPE and ceramide seemed to follow only in part 
the observed effect for PC species. The reduction of saturated LPC 16:0 and LPC 18:0 in 
vesicles was consistent with observations by Keenan et al, that LPC 16:0 and LPC 18:0 
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are enriched at the PM (Keenan and Morre, 1970). Interestingly, saturated LPE 18:0, that 
is supposed to be concentrated at the PM (Keenan and Morre, 1970) was found enriched 
in COPI vesicles. 
 
3.3.4 Mechanisms of segregation 
Based on the given data, two different mechanisms of lipid segregation during the 
formation of COPI vesicles can be envisaged (Brugger et al., 2000; Nickel et al., 1998a): 
(i) a dynamic segregation of lipids concomitant with COPI vesicle generation based on the 
molecular mechanisms of vesicle budding, and (ii) segregation of lipids before the budding 
process. Given the fact, that COPI vesicles comprise a liquid-disordered lipid composition 
and recent in vitro observations that COPI coat assembly is adapted to liquid-disordered 
domains at the Golgi complex (Manneville et al., 2008) the “segregation before budding” 
scenario seems more likely. Furthermore, the existence of SM-enriched microdomains at 
the Golgi complex (Gkantiragas et al., 2001) supports a “segregation before budding” 
situation.  
 
The characteristic, “ER-like” lipid composition of COPI vesicles might be interpreted in a 
way that COPI vesicles are exclusively involved in retrograde transport pathways. This 
scenario is in accordance with cisternal maturation (Glick et al., 1997; Bonfanti et al., 
1998; Matsuura-Tokita et al., 2006) or rapid partition (Patterson et al., 2008) of Golgi 
cisternae, where COPI vesicle would play a major role in the retrograde transport of lipids 
to the ER. Exclusive retrograde transport of COPI vesicles is supported by several 
findings (Bannykh and Balch, 1997; Mironov et al., 1997; Gaynor et al., 1998), however, 
there is strong evidence for a role of COPI vesicles in anterograde transport (Nickel et al., 
1998b; Orci et al., 1997; Orci et al., 2000; Volchuk et al., 2000). Nevertheless, high 
amounts of ER lipids in COPI vesicles do not exclude anterograde traffic since low 
amounts of SM and cholesterol in vesicles may still be sufficient for an anterograde net 
transport of these lipids. Additionally, alternative lipid transport mechanisms, such as 
Golgi-independent cholesterol transport (Urbani and Simoni, 1990) or lipid transport via 
contact sites and lipid transfer proteins (Holthuis and Levine, 2005; Lev, 2010) should be 
considered as significant contributors to lipid transport and sorting processes. 
 
Taken together, the presented data comprises an extended lipidome analysis of COPI 
vesicles in comparison to donor Golgi membranes. The analysis provided evidence that 
COPI vesicles display an “ER-like” lipid composition and supports the idea that COPI 
vesicle formation takes place at liquid-disordered domains in the Golgi complex. It will be 
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fascinating to see whether distinct populations of COPI vesicles, that are either 
characterized by different coatomer isoforms (Moelleken et al., 2007; Wegmann et al., 
2004) or by different cargo (Orci et al., 1997; Lanoix et al., 2001; Malsam et al., 2005) are 
involved in the selective transport of lipid classes and lipid species. Moreover, analyzing 
the lipid composition of other transport carriers such as COPII- and clathrin-coated 
vesicles will expand our understanding of intracellular lipid transport and sorting. 
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4 Materials and methods 
4.1 Materials 
4.1.1 Chemicals and materials 
Following chemicals and materials were used unless stated otherwise: 
 
Product (Order Number) Company 
Acetic acid, AnalaR Normapur (# 20104.334) VWR International 
Aceton, pro analysis (# 1.00014.1000) Merck, Darmstadt 
Acetyl chloride  (# 23,957-7) Sigma-Aldrich, Taufkirchen 
Ammonium acetate (# 09690) Sigma-Aldrich, Taufkirchen 
Ammonium hydrogencarbonate Merck, Darmstadt  
Ammonium hydroxide, 25% NH3  (# UN 2672) J.T. Baker, USA 
Ammonium molybdate (# 09878) Sigma-Aldrich, Taufkirchen 
ART-Tips 1000 µl reach (# 2079) Molecular Bioproducts 
ART-Tips 200 µl (# 2069) Molecular Bioproducts 
Ascorbic acid (# 3525.1) Roth, Karlsruhe  
Chloroform (# 25690) Sigma-Aldrich, Taufkirchen 
Cuvettes, polystyrol (# 67.742) Sarstedt, Nümbrecht  
DMEM (# T041-05) Biochrom, Berlin 
DMEM, inositol-free (# A8164) AppliChem, Darmstadt 
EDTA (# 147850010) Acros Organics, USA 
ESI-Chip for Triversa Nanomate (# HD_D_384 incl. sample 
tip rack, A15, 384, P/N: 1004763). Advion Biosciences, Norwich, UK 
Glass vials, 1.5 ml (# 2-7201) + Teflon lined screw caps Neolab, Heidelberg 
Glass vials, 4 ml, (# 2-7231) + Teflon lined screw caps Neolab, Heidelberg 
HPLC-grade H2O, Chromanorm (# 23595.328) VWR International 
Hydrochloric acid 37%, pro analysis Merck, Darmstadt  
Methanol (# 65543) Sigma-Aldrich, Taufkirchen 
myo-[3H]-inositol, 1 mCi/ml (# TRK912) GE Healthcare, USA 
Nanoflow probe tips (# M956230AD1) Teer Coatings Ltd, Droitwich, UK 
Pasteur capillary pipettes, 150 mM length WU, Mainz  
PBS (# L182-05) Biochrom, Berlin  
Perchloric acid 70-72% (# 1.00519.1001) Merck, Darmstadt 
Piperidine (# 41,102-7) Sigma-Aldrich, Taufkirchen 
Pipette tips, 10 µl (# 771290) Greiner Bio-One 
Potassium oxalate (# 1.05072.1000) Merck, Darmstadt 
Safe lock cups 1.5 ml (# 0030 120.094) Eppendorf, Hamburg 
Safe lock cups 2 ml (# 0030 120.068) Eppendorf, Hamburg 
Schott glass tubes (# 231751459) Duran Group, Mainz  
ThermowellTM sealing tape (# 6569) Corning Incorporated, UK 
TLC plates, Silica 60, 20x20 cm (# 1.05721.0001) Merck, Darmstadt  
Trichloracetic acid, Biochemica (# A1431) AppliChem, Darmstadt 
Triethylamine for β-imager (# 90340) Sigma-Aldrich, Taufkirchen  
Well plates 96, colorless (# 0030 128.648) Eppendorf, Hamburg 
Wheaton glass tubes (# 9-0611) Neolab, Heidelberg 
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4.1.2 Lipids 
Following internal standards and reference standards were purchased from Avanti Polar 
Lipids (Alabaster, USA): CL 14:0/14:0/14:0/14:0 (# 750332C), CL 18:1/18:1/18:1/18:1  
(# 710335C), DAG 14:0/14:0 (# 800814C), DAG 16:0/16:0 (# 800816C), DAG 16:0/18:1  
(# 800815C), DAG 18:1/18:1 (# 800811C), DAG 18:0/20:4 (# 800818C), PI(4)P 17:0/20:4 
(# LM-1901), PI(4,5)P2 17:0/20:4 (# LM-1904), Brain PI(4)P (# 840045P), Brain PI(4,5)P2 
(# 840046P), LPC 17:1 (# LM-1601), LPE 17:1 (# 110699), PI 16:0/16:0 (# 850141P), 
standards for PC mix (PC 13:0/13:0 (# 850340C), PC 14:0/14:0 (# 850345C),  
PC 20:0/20:0 (# 850368C), PC 21:0/21:0 (# 850370C)) and cholesterol (# 700000P). 
Unsaturated standards for PG mix (28:2, 40:2 and 44:2), PE mix (28:2, 40:2 and 44:2) and 
PS mix (28:2, 40:2 and 44:2) were synthesized and purified via HPLC as described 
(Koivusalo et al., 2001), DAG 17:0/17:0 (# 32-1702) was purchased from Larodan 
(Malmö, Sweden), D6-cholesterol (# 2607-0.1) was obtained from Cambridge Isotope 
Laboratories (Andover, USA). 
 
4.1.3 Instruments 
Following instruments were used unless stated otherwise: 
Instrument Company 
Quattro II (triple quadrupole mass spectrometer) Micromass, Manchester, UK 
QStar® Elite (quadrupole time-of-flight mass 
spectrometer)  
Applied Biosystems, Darmstadt 
AB Sciex QTrap® 5500 (linear ion trap triple quadrupole 
mass spectrometer) 
Applied Biosystems, Darmstadt  
Triversa Nanomate  Advion Biosciences, Norwich, UK 
Liebisch evaporator and heating device Liebisch GmbH & Co. KG, Bielefeld 
Beta imager  Biospace, France 
Scintillation counter  Perkin Elmer, USA  
 
4.2 Methods 
4.2.1 Cell culture and myo-[3H]-inositol labeling  
Labeling of HeLa cells was performed similar as described (Hama et al., 2004). Briefly, 
HeLa cells (# ATCC CCL-2.1) were maintained in 10-cm dishes in DMEM (including 10% 
fetal calf serum, 100 µg/ml penicillin, 100 µg/ml streptavidin and 2 mM glutamine) in  
5% CO2 at 37°C in a humidified incubator. Cells were grow n to ~50-60% confluence, the 
medium was replaced by inositol-free DMEM (including 10% fetal calf serum, 100 µg/ml 
penicillin, 100 µg/ml streptavidin and 2 mM glutamine) and the labeling started by the 
addition of myo-[3H]-inositol to a final concentration of 10-20 µCi/ml. The labeling time was 
typically 24-88 h until the cells reached levels of ~80-90% confluence. 
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4.2.2 Phosphorus assay (micro determination)  
Lipid phosphorus content was determined according to Rouser et al (Rouser et al., 1970). 
Endogenous lipids were extracted (see chapter 4.2.6.1) and subsequently subjected to 
the phosphorous assay. Commercially available lipids were directly subjected to the 
phosphorous assay. Briefly, lipids were provided in Teflon-sealed glass vials, dried and 
hydrolyzed for 40 min at 180°C after the addition o f 300 µl perchloric acid. After cooling 
down, 1 ml water and 0.8 ml of a freshly prepared mixture containing 0.625% ammonium 
molybdate and 2.5% ascorbic acid was added followed by incubation for 5 min at 100°C. 
After cooling down, the mixture was transferred to a cuvette and the absorption was 
measured at 797 nm. Quantification of sample phosphate amount was achieved by 
comparing to a calibration line. For the calibration line, 0, 2, 5, 10, 20, 30 and 40 nmol 
phosphate was provided from a 0.4 mM KH2PO4 solution. Calibration samples were 
processes in parallel to the lipid samples except that they were not subjected to lipid 
extraction. 
 
4.2.3 Preparation of lipid standards 
Standards delivered as powder were dissolved in chloroform except for PI(4)P 37:4, 
PI(4,5)P2 37:4, brain PI(4)P and brain PI(4,5)P2, which were dissolved in chloroform/ 
methanol/H2O (1:1:0.2, v/v/v). D6-cholesterol and cholesterol was dissolved in methanol. 
The concentration of phospholipid solutions was determined by the phosphorous assay. 
Lipid stocks were diluted to final concentrations of 1-12.5 µM. PI(4,5)P2 17:0/20:4 was 
kept at concentrations of 30-50 µM. 
 
4.2.4 Preparation of primary human T cells and TCR stimulation 
All experiment concerning the preparation of primary human T cells (Tcons) and TCR 
stimulation were performed by Angelika Schmidt (Research Group: Prof. Dr. Peter H. 
Krammer, DKFZ, Heidelberg). Human peripheral blood leucocytes (PBLs) were purified 
from Buffy coats by Biocoll™ (Biochrom, Berlin, Germany) gradient centrifugation followed 
by plastic adherence to deplete monocytes. CD4+CD25- Tcon were isolated by magnetic 
cell sorting (MACS) using the CD4-Isolation kit II and additionally depleted from  
CD25+-cells with 8µl of anti-CD25 MACS beads per 107 cells (Miltenyi Biotech). Tcons 
were rested overnight in X-Vivo 15 medium (Cambrex) supplemented with 1% Glutamax. 
Tcon were taken up in pre-warmed X-Vivo 15 medium (37°C) to ~10 7 cells/ml and 
stimulated by addition of soluble anti-CD3 (0.2 µg/ml), anti-CD28 (2 µg/ml) and goat anti-
mouse crosslinker (2 µg/ml) antibodies for indicated time periods at 37°C/ 5% CO 2. 
Stimulation was stopped by the addition of ice-cold MACS-buffer and cells were passed 
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over a LS-column (Miltenyi) on ice to mimic a coculture separation procedure. After cen-
trifugation (1,000 x g, 5 min at 4°C), Tcons were w ashed with PBS and lysed in 0.6 ml 0.5 
M TCA. 
 
4.2.5 Purification of Golgi membranes and COPI vesicles 
Golgi membranes and COPI vesicles were provided by Dr. Vincent Popoff (Research 
Group: Prof. Dr. Felix Wieland, BZH, Heidelberg). Purification of Golgi membranes was 
performed as described (Hui et al., 1998). Enzyme marker analyses (NADH-cytochrome c 
reductase, alkaline phosphodiesterase and β-N-acetylglucosaminidase) were performed 
by Ingrid Meißner (Research Group: Prof. Dr. Felix Wieland, BZH, Heidelberg). The 
galactosyltransferase assay was done as described (Roth and Berger, 1982). COPI 
vesicles were prepared from 360 µg (6 x 60 µg) purified Golgi membranes in the presence 
of rat liver cytosol (RLC) and GTPγS according to the protocol of Dr. Rainer Beck 
(Research Group: Prof. Dr. Felix Wieland, BZH, Heidelberg). As a blank control for 
quantitative lipid analysis, COPI vesicle fractions, obtained from the incubation of 360 µg 
(6 x 60 µg) Golgi membranes in the presence of RLC but in the absence of GTPγS, were 
prepared.  
 
4.2.6 Lipid extraction procedures 
4.2.6.1 Lipid extraction from GEP mitochondria for PE and CL analysis  
Yeast cell culture, isolation and purification of mitochondria was performed by Dr. Christof 
Osman (Research Group: Prof. Dr. Thomas Langer, University of Cologne) as described 
(Osman, 2009; Osman et al., 2009). Mitochondrial lipids were extracted and phosphate 
concentration was determined by the phosphorous assay. For mass spectrometric 
analysis 1.5 nmol phospholipids were extracted in Teflon-sealed glass vials in the 
presence of 50 pmol CL 56:0 and 50 pmol PE mix. Briefly 1.875 ml chloroform/ 
methanol/37% HCl (40:80:0.6, v/v/v) and x µl sample was added to the lipid standards. 
After vortexing for 20 sec, water (500 µl – x µl sample) was added followed by vortexing. 
After the addition of 500 µl chloroform and 500 µl water, the sample was vortexed 
followed by centrifugation to induce a phase separation (200 x g, 2 min at 4°C). The lower 
chloroform phase was transferred to a second glass vial and the remaining aqueous 
phase and the chloroform phase were re-extracted after the addition of 500 µl chloroform 
and 500 µl water. The washed chloroform phase of the second vial was transferred to a 
third vial and the chloroform phase of the initial vial was combined with the aqueous 
phase of the second vial followed by re-extraction. After phase separation, the chloroform 
phase of the second vial was combined with the chloroform phase of the third vial and 
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evaporated by a gentle stream of argon at 37°C. Lip ids were dissolved in 10 mM 
ammonium acetate in methanol (PE analysis) or 5 mM ammonium acetate and 0.05% 
piperidine in methanol (CL analysis) and analyzed by mass spectrometry. 
 
For TLC analysis, 1 mg mitochondria were mixed with 1.5 ml chloroform/methanol  
(1:1, v/v) and vigorously shaken for 60 min. 300 µl water was added and samples were 
vortexed for 60 s. After centrifugation (1.000 rpm, 5 min) and removal of the aqueous 
phase, the organic phase was washed with 250 µl methanol/H2O (1:1, v/v). Samples were 
then dried under a constant stream of argon. Lipids were dissolved in chloroform, 
phosphate concentration was determined according to Rouser et al, and samples were 
subjected to TLC analysis. TLC plates (HPTLC; Merck & Co., Inc.) were developed with 
chloroform/methanol/25% ammonia (50:50:3, v/v/v) followed by staining with 470 mM 
CuSO4 in 8.5% o-phosphoric acid and incubation for 10 min at 180°C . 
 
4.2.6.2 Lipid extraction from wt, ∆gep4 and ∆crd1 mitochondria  
Mitochondrial fractions were pelleted for 20 min (13,800 x g and 4°C) and resuspended in 
150 mM ammonium hydrogencarbonate (NH4HCO3) buffer. The amount of phospholipids 
was determined by the phosphorus assay. For mass spectrometry, 1.5-3 nmol phospho-
lipids per sample was extracted as described in chapter 4.2.6.1 in the presence of internal 
standards providing spike amounts of 100 pmol PC mix, 80 pmol PE mix, 80 pmol PI 32:0, 
50 pmol PS mix, 25-50 pmol PG mix and 50 pmol CL 56:0. Dried lipid samples were 
prepared for mass spectrometry as described chapter 4.2.6.1. 
 
For PGP quantification, 1.5-3 nmol phospholipids were extracted in the presence of  
25-50 pmol PG mix in Eppendorf tubes. Briefly, 750 µl chloroform/methanol/37% HCl 
(40:80:1, v/v/v) was added to the samples followed by 15 min incubation at RT. Samples 
were vortexed for 30 sec every 3 min. Phase separation was induced by the addition of 
250 µl chloroform and 450 µl 0.1 M HCl followed by 1 min vortexing and centrifugation 
(6,500 x g, 2 min at 4°C). The organic phase was tr ansferred into a new Eppendorf tube 
and evaporated. Dried lipids were dissolved in 25 mM ammonium acetate in chloroform/ 
methanol/H2O (1:1:0.05) and analyzed by mass spectrometry. 
 
For TLC analysis, 0.5 mg mitochondria were pelleted, resuspended in 750 µl chloroform/ 
methanol/37% HCl (40:80:1, v/v/v) and vigorously shaken for 15 min at 25°C. Samples 
were transferred to ice, 250 µl cold chloroform and 450 µl cold 0.1 M HCl were added and 
samples were vortexed for 1 min at 25°C. After cent rifugation at 7,500 x g for 2 min at 
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4°C, the organic phase was transferred to a new Epp endorf tube and samples were dried 
under a constant stream of argon. For one-dimensional separation of PGP, 12 nmol 
phospholipids were spotted on TLC plates that were developed with ethylacetate/ 
2-propanol/ethanol/6% ammonia (3:9:3:9, v/v/v/v) (Hegewald, 1996).  
 
4.2.6.3 Phosphoinositide extraction from myo-[3H]-inositol labeled HeLa 
cells 
Cell harvesting and phosphoinositide extraction was performed as described (Wenk, 
2007). Briefly, after transferring the cells (~5 x 106) to ice and removal of the medium, 
cells were washed two times with 10 ml cold PBS. After adding 1.2 ml cold 0.5 M TCA, the 
cells were immediately scraped off the dish, transferred to an Eppendorf tube and 
vortexed for 10 sec followed by 5 min incubation on ice. After centrifugation (13,800 x g, 2 
min at 4°C), the supernatant was discarded and the pellet washed two times with 1 ml 
cold 5% TCA/ 1 mM EDTA. For neutral extraction, the pellet was resuspended in 1 ml 
chloroform/methanol (1:2, v/v) and incubated for 10 min at RT. The sample was vortexed 
for 30 sec every 3 min. After precipitation (13,800 x g, 2 min at 4°C), the supernatant was 
transferred to a new Eppendorf tube. For acidic extraction, the remaining pellet was 
resuspended in 750 µl chloroform/methanol/37% HCl (40:80:1, v/v/v) and incubated for  
15 min at RT while vortexing the sample for 30 sec every 5 min. After transferring the tube 
to ice, 250 µl cold chloroform and 450 µl cold 0.1 M HCl was added followed by 1 min 
vortexing and centrifugation (6,500 x g, 2 min at 4°C). The lower organic phase was 
transferred to a new tube. Before drying, ~1 vol% of the neutral and the acidic extract was 
subjected to scintillation counting to determine the radioactivity. Based on the sum of 
radioactivities in the neutral extract (100 vol%) and the acidic extract (100 vol%), a typical 
myo-[3H]-inositol incorporation of 0.5-1.5% was calculated compared to the starting 
labeling amount (100-200 µCi). The organic phases were dried and stored at -20°C until 
further processing. 
 
For TLC analysis, plates were covered with 1% (w/v) potassium oxalate and 2 mM EDTA 
in 50% methanol followed by drying for 10-15 min with a blow-dryer. Dried lipid extracts 
were dissolved in appropriate volumes (20-300 µl) of chloroform/methanol/H2O  
(1:1:0.2, v/v/v) to a final concentration of ~5-15 nCi/µl. 50-200 nCi were spotted on TLC-
plates and dried (Note: to avoid saturation of the beta imager detector, only a proportion of 
each extract was spotted on the plates). The plates were developed with chloroform/ 
acetone/methanol/acetic acid/H2O (64:30:24:30:13, v/v/v/v/v) for 1.5-2 h. After drying,  
3H-PI and 3H-PIPs were visualized by the beta imager (24 h acquisition). Data evaluation 
Materials and methods 
_______________________________________________________________________ 
90 
was performed with the β-vision+ software (Biospace). The spot activities (cpm) of 3H-PI 
and 3H-PIPs were used to determine the distribution of 3H-PI, 3H-PIP and 3H-PIP2 in 
neutral and acidic extracts. 
 
4.2.6.4 Phosphoinositide extraction from HeLa cells  
HeLa cells were grown in DMEM to 80-90% confluence in a 10-cm dish (~5 x 106 cells). 
Cell harvesting was done as described (chapter 4.2.6.3). Aliquots (1-10 vol%) were taken 
from the homogenate (second wash step with 1 ml 5% TCA/ 1 mM EDTA), lipids extracted 
and quantified by the phosphorous assay. Typically, 100-250 nmol phospholipids were 
subjected to a two-step lipid extraction in Eppendorf tubes. For neutral extraction, the 
pellet was resuspended in 1 ml chloroform/methanol (1:2, v/v) and incubated for 10 min at 
RT. The sample was vortexed for 30 sec every 3 min. After precipitation (13,800 x g, 2 
min at 4°C), the supernatant was transferred to a n ew Eppendorf tube. 270 pmol  
PI(4)P 37:4 and 625 pmol PI(4,5)P2 37:4 were added to the pellet followed by acidic 
extraction. Briefly, the pellet was resuspended in 375 µl chloroform/methanol/37% HCl 
(40:80:1, v/v/v) and incubated at RT for 15 min, vortexing every 5 min for 30 sec. After 
transferring the tube to ice, 125 µl cold chloroform and 225 µl cold 0.1 M HCl were added 
followed by 1 min vortexing. Phase separation was induced by centrifugation (6,500 x g, 2 
min at 4°C) and the lower organic phase was immedia tely transferred to a new tube and 
kept on ice until further processing. For mass spectrometric analysis, 10 µl of the organic 
phase was diluted 1:2 with 50 mM ammonium acetate in chloroform/methanol (1:1, v/v). 
 
4.2.6.5 Lipid extraction from HeLa Golgi membranes for DAG quantification 
Preparation of Golgi membranes from HeLa cells was performed by Dr. Frank Anderl 
(Research Group: Prof. Dr. Felix Wieland, BZH, Heidelberg) as described in his PhD 
thesis (Anderl, 2008). Lipid extraction from Golgi membranes was done as described in 
chapter 4.2.6.1 in the presence of 80 pmol DAG 17:0/17:0. Dried lipids were dissolved 10 
mM ammonium acetate in methanol and subjected to mass spectrometry. 
 
4.2.6.6 Lipid extraction from NRK Golgi membranes for DAG quantification 
Preparation of Golgi membranes from NRK cells and ilimaquinone (IQ) treatment was 
performed by Dr. Josse van Galen (Research Group: Prof. Dr. Vivek Malhotra, Centre for 
Genomic Regulation, Barcelona, Spain). Briefly, ~10-100 µg Golgi membranes were 
incubated for 1 h in 25 µM IQ in DMSO or DMSO (control) in 50 mM Tris pH 7.4,  
150 mM KCl, 2 mM DTT, 30 mM MgCl2, 1 mg/ml BSA, 250 mM sucrose and protease 
inhibitors. Golgi membranes were pelleted and resuspended in Tris buffered saline 
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followed by a two-step lipid extraction in the presence of 20 pmol DAG 17:0/17:0 as 
described in chapter 4.2.6.8. Dried lipids were dissolved in 10 mM ammonium acetate in 
methanol and DAG quantification was performed in neutral lipid extracts. 
 
4.2.6.7 Lipid extraction from primary human T cells  
T cell lysates were either immediately processed or snap frozen and stored at -80°C until 
further processing. The storage time was restricted to a maximum of 2-3 weeks to 
minimize sample degradation. Prior to lipid extraction, TCA lysates were precipitated 
(13,800 x g, 2 min at 4°C) and pellets washed two t imes with 1 ml cold 5% TCA/  
1 mM EDTA. After centrifugation (13,800 x g, 2 min at 4°C), the supernatant was dis-
carded and lipids were extracted from the pellet by a two-step extraction in Eppendorf 
tubes (similar as described in chapter 4.2.6.4). Prior neutral extraction, 15 pmol  
DAG 17:0/17:0 and 250 pmol PC mix was spiked to the pellet and lipids were extracted 
with 750 µl chloroform/methanol (1:2, v/v) by incubating 10 min at RT and vortexing every 
3 min for 30 sec. After centrifugation (13,800 x g, 2 min at 4°C), the supernatant was care-
fully removed from the pellet and transferred to a new tube. The supernatant was sub-
jected to a second extraction after the addition of 250 µl chloroform and 450 µl water. 
Phase separation was induced by centrifugation (6,500 x g, 2 min at 4°C) and the lower 
phase was transferred to a new tube. Dried lipids were dissolved in 10 mM ammonium 
acetate in methanol and subjected to mass spectrometry. 
 
Prior acidic extraction of PIPs, 15 pmol PI(4)P 37:4 and 160 pmol PI(4,5)P2 37:4 was 
spiked to the remaining pellet (which was kept on ice all the time). The pellet was 
resuspended in 375 µl chloroform/methanol/37% HCl (40:80:1, v/v/v), incubated at RT for 
15 min and vortexed every 5 min for 30 sec. After transferring the tube to ice, 125 µl cold 
chloroform and 225 µl cold 0.1 M HCl were added followed by 1 min vortexing. Phase 
separation was induced by centrifugation (6,500 x g, 2 min at 4°C). The lower organic 
phase was immediately transferred to a new tube and kept on ice until further processing. 
For mass spectrometric analysis, an aliquot (10 µl) of the organic phase was diluted 1:2 
with 50 mM ammonium acetate in chloroform/methanol (1:1, v/v). 
 
4.2.6.8 Lipid extraction from Golgi membranes and COPI vesicles  
Golgi membranes and COPI vesicles were subjected to a modified two-step extraction 
procedure based on Ejsing et al (Ejsing et al., 2009). Golgi input (2-4 µg protein) and 
vesicle fractions (-/+ GTPγS) were extracted in Eppendorf tubes in the presence of  
125-150 pmol PC mix, 125 pmol SM mix, 75 pmol PE mix, 75 pmol PS mix, 100-150 pmol 
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PI 32:0, 10 pmol ceramide mix, 150 pmol D6-cholesterol, 150 pmol pl-PE mix, 15 pmol 
LPC 17:1 and 15-25 pmol LPE 17:1. To determine experimental-dependent response 
factors for cholesterol quantification, 100 pmol, 200 pmol and 400 pmol cholesterol were 
processed together with the samples. A blank extraction (only lipid standards) was in-
cluded to correct for background derived ion signals. 
 
Neutral extraction was performed by adding 990 µl chloroform/methanol (17:1, v/v) and 
200 µl water - x µl sample followed by 30 min shaking at 1,400 rpm and 20°C. Phase 
separation was induced by centrifugation (6,500 x g, 2 min at 4°C) and the lower organic 
phase was transferred to a new tube. Before drying, an aliquot (150 µl) of the chloroform 
phase was transferred to a new tube for cholesterol acetylation according to Liebisch et al 
(Liebisch et al., 2006). Briefly, dried lipids were incubated for 1 h in 50 µl acetylchloride/ 
chloroform (1:5, v/v) followed by drying. For acidic extraction, the remaining aqueous 
phase (~200 µl) was adjusted to 0.1 M HCl by adding 10 µl 2 M HCl followed by the 
addition of 375 µl chloroform/methanol/37% HCl (40:80:1, v/v/v) and 125 µl chloroform. 
After vortexing for 1 min a phase separation was induced and the lower organic phase 
transferred to a new tube and dried.  
 
For mass spectrometric analysis, neutral and acidic extracts were dissolved in 10 mM 
ammonium acetate in methanol. PC, SM, LPC, PE, pl-PE, ceramide and cholesterol 
analysis was performed in neutral extracts. PS and PI were analyzed in acidic extracts 
and LPE was analyzed in neutral and acidic extracts. For SM analysis, neutral and acidic 
extracts (dissolved in 10 mM ammonium acetate in methanol) were pooled and subjected 
to mild alkaline hydrolysis. Briefly, after solvent evaporation, 4 ml 12.5% ammonia in 
methanol was added followed by incubation for 2.5 h at 50°C. The ammonia/methanol 
mixture was evaporated and lipids dissolved in 10 mM ammonium acetate in methanol 
followed by mass spectrometric analysis. 
 
4.2.7 Mass spectrometry 
4.2.7.1 Quattro II  
Quantification of PC, SM, PE, pl-PE, PI, PS, LPC, LPE, ceramide, PG, PIP and PIP2 and 
qualitative analysis of PGP was performed in positive ion mode with the Quattro II 
operated by the Mass Lynx software. 10 µl of lipid sample was loaded into a nanoflow 
probe tip that was subsequently mounted into a nano-ESI source (Z spray). Argon was 
used as collision gas at a nominal pressure of 2.5 x 10-3 millibar. The cone voltage was 
set to 30 V (50 V for PC analysis). The quadrupoles Q1 and Q3 were operated at unit 
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resolution. Detection of PC and SM was achieved by precursor ion scanning for the 
fragment ion m/z 184 (CE: 32 eV). LPC and ceramide were measured by precursor ion 
scanning for the fragment ion m/z 184 (CE: 20 eV) and m/z 264 (CE: 30 eV), respectively. 
(L)PE, PI, PIP, PIP2, PS, PG and PGP measurements were carried out by scanning for 
neutral losses of 141 Da (CE: 20 eV), 277 Da (CE: 30 eV), 357 Da (CE: 30 eV), 437 Da 
(CE: 35 eV), 185 Da (CE: 20 eV), 189 Da (CE: 20 eV) and 269 Da (CE: 25 eV), 
respectively. Detection of pl-PE was achieved by scanning for plasmalogen-specific 
precursor ions (Zemski Berry and Murphy, 2004), m/z 364 at 20 eV (16:0p), m/z 390 at  
18 eV (18:1p) and m/z 392 at 20 eV (18:0p). 20-50 MCA spectra were acquired for every 
scan. For data processing, spectra were smoothed (Savitzky Golay, peak width: 0.85 Da, 
number of smoothes: 4) and background subtracted (polynomial order: 1, below  
curve %: 10, tolerance: 0.01 and flatten edges). The spectrum peak list was exported and 
processed with a self programmed tool for correction of isotopic overlap and mass-
dependent intensity differences. The data was transferred to Excel for final lipid 
quantification. 
 
4.2.7.2 QStar Elite and QTrap 5500 
Quantification of DAG, PIP, PIP2, PGP and cholesterol in positive ion mode and 
quantification of CL in negative ion mode was performed with the QStar Elite operated by 
the Analyst 2.0 Software. Quantification of PIP and PIP2 was also achieved with the  
AB Sciex QTrap 5500 operated by the Analyst 1.5.1 Software. Before infusion, lipid 
extracts (in Eppendorf tubes) were subjected to centrifugation (13,800 x g, 5 min at 4°C) 
to remove debris. 20 µl of lipid samples were loaded into 96-well plates and sealed with 
sealing tape. Lipid infusion and ionization was achieved with the Triversa Nanomate 
operated with the ChipSoft Software under the following settings: sample infusion  
volume: 10 µl, volume of air to aspirate after sample: 1 µl, air gap before chip: enabled, 
aspiration delay: 0 sec, pre-piercing: with mandrel, spray sensing: enabled, cooling temp-
erature: 12°C, gas pressure: 0.5 psi. Following ion ization mode and solvent-dependent 
settings were used: 
 
 
Positive ion mode Negative ion mode 
Infusion solvent 25 mM ammonium  
acetate in chloroform/ 
methanol/(H2O) 
10 mM ammonium 
acetate in methanol 
5 mM ammonium 
acetate + 0.05% 
piperidine in methanol 
Vent headspace No Yes Yes 
Pre-wetting 2x 1x 1x 
Voltage (kV) 1.3-1.6 1.3-1.6 -1.1 
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Mass spectrometric analysis was performed under the following, instrument-dependent 
settings: 
 
 
4.2.7.3 Acquisition methods - QStar Elite  
4.2.7.3.1 Product ion analysis of CL species 
CL species (all combinations of fatty acids 16:0, 16:1, 16:2, 18:0, 18:1 and 18:2, see 
Table 1) were analyzed by product ion analysis of singly-charged ions [M-H]- at a CE of  
-85 eV. The TOF mass analyzer was set to m/z 200-350 to monitor fatty acid fragment 
ions of the corresponding CL precursors. Trapping of ions in Q2 (peak enhancement) was 
applied to a mass of m/z 275. Data acquisition was done in the continuum mode for  
40 min, 80 cycles were acquired at a cycle time of 30 sec. For quantification, the peak 
areas of CL-derived fatty acid fragments were extracted from the respective product ion 
spectra through the “Extract Fragments” script. Isotope correction was done manually. 
Values were corrected for response factors of standards. 
 
4.2.7.3.2 Product ion analysis of PGP species 
Quantification of PGP was achieved by product ion analysis of PGP species as identified 
in lipid extracts of ∆gep4 mitochondria (Figure 23 B). As a PGP standard is commercially 
not available, PGP quantification was performed using the PG standard mix, assuming 
that PG and PGP show the same mass spectrometric response behavior. Product ion 
analyses were conducted at a CE of 25 eV. The TOF mass analyzer was set to  
m/z 450-750 to monitor fragments derived from neutral losses of 189 Da (PG) and 269 Da 
(PGP) of the corresponding PG and PGP precursors. Trapping of ions in Q2 (peak 
enhancement) was applied to a mass of m/z 600. Data acquisition was done in the 
continuum mode for 19 min, 60 cycles were acquired at a cycle time of 19 sec. 
Quantification of the parent molecules was done as described for CL. 
 
 
QStar Elite QTrap 5500 
Curtain Gas 10 10 
CAD Gas 2 5 
Operating pressure (torr) 2.5 x 10-5 1.6 x 10-5 
Interface heater temperature IHT (°C) 40 40 
Declustering potential (DP) 40 100 
Focusing potential (FP) 200 - 
Declustering potential 2 (DP2) 10 - 
Entrance potential (EP) - 7 
Collision cell exit potential (CXP) - 19 
Detector (CEM) 2500 2100 
Quadrupole resolution  Unit (Q1) Unit (Q1 and Q3) 
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4.2.7.3.3 Product ion analysis of PIP and PIP2 species 
Quantification of brain PIPs in positive ion mode was done by product ion analysis of PIP 
and PIP2 precursors (Table 4) conducted at CEs of 25 eV for PIP and 35 eV for PIP2, 
respectively. The TOF mass analyzer was set to m/z 500-700 to monitor neutral loss 
derived fragments. Trapping of ions in Q2 (peak enhancement) was applied to a mass of 
m/z 600. Data acquisition was done in the continuum mode for 32 min, 100 cycles were 
acquired at a cycle time of 19 sec. Quantification of the parent molecules was done as 
described for CL. 
 
4.2.7.3.4 Product ion analysis of D6-cholesterol and cholesterol  
Quantification of cholesterol was achieved in positive ion mode by product ion analysis of 
cholesterol acetate (m/z 446.4) and D6-cholesterol acetate (m/z 452.4) at a CE of 12 eV 
similar as described (Ejsing, 2006). The TOF mass analyzer was set to m/z 350-400 to 
monitor neutral loss (77 Da = C2H7NO2) derived fragments at m/z 369.36 (cholesterol) and 
m/z 375.39 (D6-cholesterol). Trapping of ions in Q2 (peak enhancement) was applied to a 
mass of m/z 375. Data acquisition was done in the continuum mode for 5 min, 150 cycles 
were acquired at a cycle time of 2 sec. Quantification of the parent molecules was done 
as described for CL. 
 
4.2.7.3.5 DAG MPIS 
MPIS of 18 DAG-specific MAG-H2O fragments (Table 2) was performed at a CE of 25 eV. 
44 MCA spectra for every precursor ion scan were acquired. The TOF mass range was 
set to m/z 250-400. Trapping of ions in Q2 (peak enhancement) was applied to m/z 327.3. 
Q1-scanning was done in the profile mode with a step size of 0.2 Da. MPIS spectra were 
evaluated with the Lipid Profiler software (V1.0.99, Applied Biosystems) under the 
following settings: smoothing: enabled, deisotoping: enabled, PIS mass tolerance: 0.3 Da. 
Peak intensities where exported as “corrected areas” and evaluated in Excel. 
 
4.2.7.4 Acquisition methods - QTrap 5500 
4.2.7.4.1 Neutral loss scanning and MRM - PIP and PIP2 
Quantification of PIP and PIP2 was achieved by scanning for neutral losses of 357 Da and 
437 Da at CEs of 25 eV and 35 eV, respectively. Neutral loss scans were performed in the 
profile mode (step size 0.1 Da) at a scan rate of 200 Da/s. For every scan mode 100-500 
MCA spectra were accumulated. For quantification, the peak intensities (cps) were 
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extracted from the spectra and further evaluated in Excel or by self-programmed software 
tools. 
 
Quantification of PIP 38:4 and PIP2 38:4 in primary human T cells was also done by 
multiple reaction monitoring (MRM). Following Q1-Q3 transitions were monitored for PIP 
species: m/z 970.5  m/z 613.4 (PI(4)P 37:4) and m/z 984.6  m/z 627.6 (PIP 38:4) at a 
CE of 25 eV. For PIP2 species: m/z 1050.5  m/z 613.5 (PI(4,5)P2 37:4) and m/z 1064.5 
 m/z 627.5 (PIP2 38:4) at a CE of 35 eV. The dwell time was set to 100 msec. 100-200 
cycles were acquired for PIP transitions and 720 cycles were acquired for PIP2 transitions.  
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